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The total synthesis of 8,9-dehydro-epothilone C (98) is reported. Compound 98 
has been prepared employing a convergent strategy that is based on the 
consecutive assembly of building blocks 41, 58, and 88 into diene 95 and 
subsequent RCM-mediated macrocycle formation. The aldol reaction between 
aldehyde 88 and ketone 58 delivered the required 6R, 7S diastereoisomer 89 with 
moderate selectivity. RCM with diene 95 was highly E selective giving efficient 
access to 8,9-dehydro epothilone C (98).  
 
Innerhalb des Projekts gelang die Totalsynthese von 8,9-dehydro-epothilon C. Die 
im rahmen des Projekts synthesierte Verbindung kommt in der natur nicht vor, 
besitz jedoch auf Grund der Doppelbindung in 8,9 eine Vorzugkonformation für 
tubulin, so dass von einer interesanten biologischen Wirkung ausgegangen werden 
kann. Für die Synthese waren die Schlüsselbausteine 41, 58, und 88 erforderlich. 
Die bildung eines einzigen 6R,7S-Diastereoisomers bei der Aldol-kondensation 
des Ethylketone 58 mit dem Aldehyde 88 erhalten wurden. Ringschluß durch 
Olefin-Metathese führten dann zu den 8,9-dehydro-epothilon C (98). 
 
 
This doctoral thesis was carried out from April 2005 until January 2010 at the 
Otto-Von-Guericke Universität Magdeburg under guidance of Professor Dr. 
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Abbreviations  
 
Ar  Aryl 
Ac  Acetyl 
AIBN  2,2’-azobisisobutyronitrile 
arom  Aromatic 
aq.  Aqueous 
AcOH  Ethyl Acetate 
9-BBN  borabicyclo[3.3.1]nonane 
(R)-BINAP (R)-(-)-2,2’-bis(diphenylphosphino)-1,1’-binaphthaline 
(S)-BINOL (S)-(-)-1,1’-bi-2-naphtol 
Bn  Benzyl 
Boc  tert-butyloxycarbonyl 
b.p.  Boiling point 
Bu  Butyl 
tBu  tert-butyl 
tBuOH  tert-butyl alcohol 
CAN  Ceric ammonium nitrate 
calcd.  Calculate 
Cbz  Benzyloxycarbonyl 
CH3CN Acetonitrile 
COSY  Corelated spectroscopy 
m-CPBA meta-chloroperoxybenzoic acid 
CSA  10-camphorsulfonic acid 
Cy  Cyclohexyl 
de  Diastereomeric excess 
DEPT  Distortionless enhancement by polarization transfer 
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DHP  Dihydropyran 
DIBAL Diisobutylaluminium hydride 
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DMAP  Dimethylaminopyridine 
DMF  N,N-dimethylformamide 
DMSO  Dimethyl sulfoxide 
EDCI  1-(3-dimethylaminopropyl)-3-ethylcarbodiimide 
EI  Electron-impact 
Eqv  Equivalent 
ESI  Electrospray ionization 
Et2O  Diethyl ether 
EtOH  Ethanol 
FAB  Fast-atom bombardment 
FD  Field-desorption 
FT-ICR Fourier transforms ion cyclotron resonance 
GC  Gass chromatography 
GTP  Guanosine triphosphate 
HMBC Heteronuclear multiple bond correlation 
HMDS  bis(trimethylsilyl)amide 
HMPA  Hexamethylphosphoric triamide 
HPLC  High performance liquid chromatography 
HRMS  High resolution mass spectrometry 
HSQC  Heteronuclear single quantum coherence 
HYTRA 2-hydroxy-1,2,2-triphenylethyl acetate 
Ipc  Isopinocampheyl 
IR  Infrared 
LDA  Lithium diisopropyl amide 
Me  Methyl 
MeOH  Methanol 
MOM  Methoxymethyl 
m.p.  Melting point 
MS  Mass spectrometry 
NBS  N-bromosuccinimide 
NIS  N-iodosuccinimide 
NMO  N-methylmorpholine N-oxide 
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NMR  Nuclear magnetic resonance 
NOESY Nuclear Overhauser effect spectroskopy 
OTf  Trifluoromethanesulfonate 
PCC  Pyridinium chlorochromate 
PG  Protecting group 
Ph  Phenyl 
Piv  Pivaloyl 
PMB  Para-methoxybenzyl 
PPTS  Pyridinium-4-toluenesulfonate 
i-Pr  Isopropyl 
Py  Pyridine 
RCM  Ring closing metathesis 
Rf  Retention factor 
SAMP  (S)-(-)-1-amino-2-(methoxymethyl)pyrolidine 
TBAF  tetra-n-butylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
TBDPS tert-butyldiphenylsilyl 
TBSOTf tert-butyldimethylsilyl trifluoromethanesulphonate 
TEMPO 2,2,6,6-tetramethylpiperidine-1-oxyl 
TFA  Trifluoroacetic acid 
THF  Tetrahydrofuran 
TIPS  Triisopropylsilyl 
TLC  Thin layer chromatography 
TOCSY Total corelation spectroscopy 
TPAP  tetra-n-propylammonium perruthenate 
Troc  2,2,2-trichloroethyl oxycarbonyl 
Ts  para-toluenesulfonyl, “tosyl” 
pTsOH para-toluenesulfonic acid 
UV  Ultraviolet 
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Chapter 1 
 
Introduction  
 
1.1. Background 
 
At the beginning of the last century the word “cancer” was not even 
mentioned as a known disease in medicine, but today cancer is a growing public 
health problem, and in Europe and USA it is the second leading cause of death, 
after the cardiovascular disease.[1] According to studies from the American Cancer 
Society (ACS) in 1997 in the USA alone around 560.000 people died of different 
cancers: that is more than 1.500 people a day, averaging approximately one death 
per minute.[2] These fearful facts motivated many interdisciplinary research  
groups around  the world  to investigate, and produce drugs against these diseases. 
More often the quantity of biologically active products obtained from natural 
sources are insufficient, that’s why the main task of the synthetic chemists is to 
develop and to optimize convergent total syntheses with maximum yields, high 
stereoselectivity in the fewest possible reaction steps.  
A major share of the anticancer drug market is commanded by the 
complex diterpene taxol® (paclitaxel), whose discovery from the Pacific Yew Tree 
in 1971 and the culmination of years of research into a billion dollar drug today 
represents a remarkable story. Developed and sold by Bristol-Myers Squibb in the 
1990s, taxol® is currently available in more than 60 countries. It  is  mainly  used  
for the treatment of a variety of solid tumors commonly encountered  e.g  ovarian  
and  breast cancers.[3,4] The success story of taxol demonstrated once again the 
wealth  of  mother  nature  in  terms  of  biologically  active molecules as cures for 
disease.[5,6] These stories will certainly not be the last: in the late 1980s, a new tale 
of cytotoxic natural products began to unfold. The epothilones A and B (see figure 
1) were discovered by Höfle, Reichenbach, and their coworkers at the 
Gesellschaft für Biotechnologische Forschung (GBF) in Germany.[7]  
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1. R = H    : Epothilone A
2. R = Me  : Epothilone B
3. R = H    : Epothilone C
4. R = Me  : Epothilone D
5. R = H    : Epothilone E
6. R = Me  : Epothilone F
 
                   
Figure 1. Structures of The Naturally Occurring Epothilones. 
 
The structural modification and biological investigation of the epothilone 
became a very interesting synthetic target for many scientists all over the world 
due to the fact that they extremely possess a high activity against certain 
cancertypes, [8] as well as the advantages compared to the billion dollar anticancer 
drug Taxol® in terms of potency and effectiveness against drug-resistant tumor 
cells of the epothilone and their complexity in terms of synthesis. Currently the 
epothilones and their analogues appeared as one of the most promising candidates 
for cancer chemotherapy.  
Several research group started efforts on the total synthesis of epothilones 
which dominated with Danishefsky, Nicolau and Schinzer publishing their 
synthesis a few weeks apart.[9] An improved route for the totalsynthesis of the 
epothilones was further investigated by Schinzer et al.: the retrosynthetic analysis 
showed that aldol reactions play an important role in the stereoselective synthesis 
of the epothilones.  
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1.2. Epothilone and Their Biological Activity 
 
The epothilones A and B (see figure 1) were discovered in the late 1980s, 
by Höfle, Reichenbach, and their coworkers at the Gesellschaft für 
Biotechnologische Forschung (GBF) in Braunschweig, Germany.[7] These 
compounds were isolated from culture extracts of the cellulose-degrading  
myxobacterium  Sorangium  cellulosum (Myxococcales; strain So ce90), first 
found in soil collected from the banks of the Zambesi River in South Africa (see 
figure 2). Although   the   gross structures of the epothilones were revealed in the 
original German patent by Höfle et al. in the early 1990´s [10] and by the Merck 
group in 1995,[11] it was not  until July 1996 that the absolute stereochemistry of 
the epothilones A and B was reported by the GBF scientist. [11] The structural 
assignments were made on the basis of spectroscopic[12,13] and X-ray 
crystallographic data,[12] and  the  compounds  were  named  epothilone  after  
their structural subunits, epoxide, thiazole and ketone. 
The epothilone possess both in vitro and in vivo, a remarkable antifungal 
effect against Oomyceten, e.g. Phytophtora infestans, the causative agents of the 
dreaded potato-blight disease. But the antifungal activity was coupled with 
substantial plant toxicity, so that further studies were stopped. Soon it was 
discovered that the compounds also had powerful activities against mouse 
fibroblast and leukemia cells and strong immunosuppressive action as revealed by 
their cytotoxicity against human T-cells. It was not until 1995, when a team from 
Merck in the USA reported their findings on the mode of action of epothilone, that 
interest in these compounds resurfaced again, this time with much more 
excitement and momentum. During a high-throughput screening program to 
discover taxol-like tubulin polymerization agents, the Merck group subjected tens 
of thousands of compounds to biological assays.  
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Further investigation of compounds showing homology to the epothilones, 
such as the 16-mebered macrocyclic substances like podophyllotoxine, 
chalcomycin and vinblastine, revealed no active compounds. The uniqueness of 
the epothilones immedietly placed them in the same class as taxol, whose tubulin-
binding mechanism of action was discovered by Horwitz in 1979. The Merck 
group compared the effects of the epothilones and taxol on tubulin and 
microtubules and reported higher potencies for both epothilones A and B as 
tubulin polymerization agents (epothilone B > epothilone A > taxol).  
Most significantly, all three  compounds  were  shown  to  compete  for  
the  same binding site within their target protein.[12,14] Furthermore, the 
epothilones were found to exhibit similar kinetics of taxol in their induction of 
tubulin polymerization, and gave rise to microscopic pictures of stabilized 
microtubules and damaged cells.[12] Perhaps the most exciting property of the 
epothilones is their superiority compared to taxol® as a chemotherapeutic agent, 
particularly MDR cell lines, including those resistant to taxol.  In some of the 
cytotoxicity experiments, epothilone B demonstrated a 2000 ± 5000-fold higher 
potency than taxol, a striking enough observation to awaken and stimulate the 
interest of many in the academic community and the pharmaceutical industry. 
 
 
                                    (a)                                                        (b) 
Figure 2.  (a). Myxobacterium  Sorangium  cellulosum (Epothilone) 
                (b).  Taxus Breviola (Taxol®) 
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1.3. Structure and Activity Relations of Epothilones 
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                 Figure 3. Structure- Activity Relationship of The Epothilones 
 
The structure-activity relationship (SAR) of the epothilones has been 
extensively studied. [15-19] Since the first synthesis of epothilone in 1996, hundreds 
of analogues have been reported and tested. [20]   Figure 3 represents epothilone, 
divided in five regions A-E, in order to simplify the SAR discussion. 
Region A (C5-C8) is highly sensitive to any kind of modification: 
epimerization at C8 [21] or addition/removal of the methyl group at C8 [21] will 
considerably lower the cytotoxicity. Removal of C6 or C7 substituents or 
reduction of the ketone at C5 also leads to loss of biological activity. The 
sensitivity of region A suggests that it plays an important role in the binding to the 
active site. [22] 
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Region B (C9-C11) is also important as region A which is highly sensitive 
to any kind of modification: the C10-methyl analogue was found to be inactive 
[23]
, but hydroxyl [24] and fluoro [25] groups are tolerated at C11. Except in the case 
of the 18-membered ring analogue of epothilone A (which led to significant 
tubulin polymerization [26]), change in the ring size results in considerable loss of 
biological activity. [26]   The C10-C11 olefin analogue, also known as epothilone 
490 (Figure 4), gives very promising results in vitro but has disappointing results 
in vivo, due to the hydrolysis of the lactone. [27]   Recently, Danishefsky et al. 
reported a C9-C10 trans analogue of epothilone D, which was nearly three times 
as active as the parent compound. This can be rationalized by the impact of the 
trans double bond on the polypropionate region. 
 
O
O OOH
OH
S
N
9
10
 
                                          Figure 4. Epothilone 490 
 
In contrast, changes in Region C (C12-C14) are well tolerated: both 
epoxide and olefin analogues are active [27, 28]. However, epothilone A and B 
(C12-C13 epoxide) are about four to 20 times more active than the corresponding 
olefinic compounds (epothilone C and D).   However, Nicolaou et al reported a 
variety of active cyclopropane (both cis and trans) and cyclobutane analogues [29-
31]
, proving that the hydrogen bond between the epoxide and the C3 hydroxyl is 
not crucial for activity, thus the role of the epoxide is mainly conformational. 
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The side chain (Region D) is revealing less tolerance than region C 
analogues. The direct attachment of the aromatic moiety at C15, or replacement of 
the methyl group at C20 with bulkier substituents, results in the loss of 
cytotoxicity. Furthermore, the replacement of the C16 methyl group with an ethyl 
group, and replacement of the thiazole ring turned out to have negative effects.  In 
particular, a methylsulfanyl replacement for the methyl group on the thiazole 
moiety (Figure 5) enhances the potency compare to the natural epothilone.[31,33] 
Recently, Nicolaou [30] reported a 12,13-cis cyclopropane methylsulfanyl analogue 
of epothilone B (Figure 6), that is six times more active than epoB against the 1A9 
ovarian carcinoma cells. Finally, change of the C15 stereochemistry leads to loss 
of the biological activity. [32] 
S N
OH
O N
N
N S N
SMe
 
 
Figure 5.  Side Chain Modifications with the Nitrogen at the Same Position as    
The Natural Product 
 
Region E (O16-C4) hardly tolerates any changes. Indeed, inversion of the 
C3 stereochemistry [21] or substitution of the gem dimethyl group at C4 by a 
cyclopropane [34] both resulted in significant loss of activity. Moreover, the 
presence of an E-olefin at C2-C3, which is believed to rigidify the C1-C3 
backbone, considerably reduces the biological activity.   
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It has been proposed that a hydrogen bond between the C3 hydroxyl and C1 
ketone plays an important role from a conformational point of view. [19]  
O
O OOH
OH
S
N
MeS
H2C
CH3
                
Figure 6. 12,13- cis Cyclopropane Methylsulfanyl EpoB 
 
However, when the C3 hydroxyl is replaced by a cyano group [35], the 
analogues are active in both tubulin polymerization and cytotoxicity assays. Thus, 
the hydrogen bond, if present, is not crucial for cytotoxicity. Lactam analogues 
usually have clearly inferior tubulin polymerizing and cytotoxic potencies than the 
corresponding lactone. One important exception is 15-(S)-aza-epoB (Figure 7), 
which has comparable properties to Taxol® in both assays[36] and has been 
launched to clinical trials.[37] In fall of 2007 the FDA (Food and Drug 
Administration) released it to the market. BMS (Bristol Meyer Squibb) is selling it 
as Ixempra® against breast cancer and this is the first epothilone on the market. 
The lactam seems to be more stable than the lactone toward metabolic cleavage. 
 Several other epothilones are in late clinical trials at the moment. Novartis 
has just finished phase III clinical trials with epothilone B (Patupilone®) and 
Bayer Schering Pharma has placed ZK-Epo (Sagopilone®), a fully synthetic 
epothilone, in phase II clinical trials. 
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Figure 7. 15- (S)- aza-epoB. 
 
 
1.4. Chemistry of the Epothilones 
 
Soon after the recognition of the importance of the epothilones, a number 
of groups around the world began to pursue strategies for their total synthesis. 
Only few months after  the  structure  of  these  macrolides  was  published  the  
research  groups  of  S.  J. Danishefsky,[38] K. C. Nicolaou,[39] and D. Schinzer[40] 
were able to present independently successful total syntheses of epothilones A and 
B. Thereafter many other research groups have published contributions to the 
existing synthetic strategies as well as new total syntheses, and assays [41] of the 
biological role of epothilones. Within the scope of the general introduction of this 
thesis it is not possible to represent complete scope of literature on this field. 
Therefore only a short selection of the first total syntheses is included. 
 
1.4.1. The Danishefsky Strategies to Epothilones 
 
The first total synthesis of both epothilones A and B including the desoxy 
precursors epothilones C and D respectively, were carried out in the working  
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group of S. J. Danishefsky, who made major contributions in the field of 
epothilone research. In the published synthesis a number of interesting reactions 
and synthetic sequences were used as a means to install functionality and control 
stereochemistry. For the construction of the macrocycle, Danishefsky and co-
workers applied three main strategies, which include a macroaldolization 
reaction[42], an olefin metathesis approach and a macrolactonization procedure.[42] 
In their first published total synthesis of epothilone A and later also of epothilone 
B, two key-step reactions were employed, namely a stereospecific Suzuki-type 
cross-coupling for combining two synthetically obtained fragments, and a  
macrocyclization aldol reaction for the ring formation (see Figure 8).                                                                   
O
O OOH
OH
HS
N
R
Olefin Metathesis
1
2
3
4 5 6
7
8
9
10
11
12
13
14
15
Macrolactonization
Macroaldolization
Suzuki Coupling
Aldol Reaction
Figure 8.  Danishefsky et al. Strategic Bond Disconnections Applied in the Total     
                 Synthesis of The Epothilone A and B 
 
The synthesis of fragment C3-C11 started with the formation of the 
dihydropyran ring 10 by a TiCl4 catalyzed stereoselective cyclocondensation of 
an enantiomerically pure aldehyde 8 with the Danishefsky diene 9 (see Scheme 
1). The chirality of aldehyde 8 determines the configuration of the new 
stereocenters in the condensation product 10. Thereafter followed a 
stereoselective reduction of the keto group with lithium aluminium hydride and 
the double bound was converted via a Simmons-Smith reaction to the 
cyclopropane derivative 11. The opening of the cyclopropane ring was performed 
using iodomethyl N-iodosuccinimide (NIS) in methanol, which leads to  
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intermediate 12. Compound 13 was obtained after subsequent radical 
dehalogenation of iodide 12 to introduce the geminal methyl groups  followed by 
protection of the  hydroxy  moiety,  and  thioacetalization  of  the  intermediary  
formed  aldehyde. 
Additionally, 13 was a key building block, because it was also suitable for 
the alternative synthetic routes to epothilone and its analogues, reported later 
by Danishefsky et al.. Further silyl protection of the new formed hydroxyl group 
in 13, followed by cleavage of the benzyl group, then Swern oxidation and Wittig 
reaction transformed the key building block 13 to the methoxyvinyl ether 14. 
The product  14  includes  the  centers  C6  and  C8,  which  have been set in  the  
correct configuration of the target molecule. Later this vinyl ether was 
hydrolysed with p-toluenesulfonic acid to the aldehyde which was reacted with 
methlytriphenyl-phosphonium bromide and the acetal 15 was obtained through a 
subsequent transacetalization. Compound 15 represents the C3-C11 fragment of 
the desired carbon skeleton, which is one of the two main building blocks 
necessary for the synthesis of both epothilone A and B as well. Sequential 
formation and opening of the dihydropyran system was the key tactic for 
introduction of the stereochemistry into the final open-chain intermediate 15. 
The second building block C12-C15, employed in the macroaldolization 
strategy of Danishefsky et al., contains the side chain with the aromatic 
moiety. Initially the desired stereochemistry of the C12-C15 fragment was 
established through the use of the enantiomerically pure starting material (R)-
glycidol 16 as a starting material, where the primary hydroxyl group was protected 
with dihydropyran (see Scheme 2). Subsequent opening of the epoxide leads to a 
secondary alcohol, which was protected as methoxymethyl ether giving compound 
17. Cleaving of the tetrahydropyran moiety, followed by Swern oxidation and 
subsequent Grignard reaction, yielded the methylketone 18 after a second 
oxidation. This compound was reacted with the Emmons reagent 19 and the silyl 
group was exchanged with iodine using N-iodosuccinimide. Thereafter followed 
hydroboration whereby the (Z)-iodoalkene 20 was produced. Finally, the 
methoxymethyl ether 20 was cleaved, and the resulting compound was 
acetylated to give the product 21.   
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Scheme 1. Synthesis of The C3-C11 Key Fragment 15 
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Scheme 2. Synthesis of The C12-C15 Key Fragment 21 
 
 
Shortly afterwards the successful synthesis of epothilone A, 
Danishefsky et al. also published also a convergent total synthesis of 
epothilone B, applying the same macroaldolization strategy for ring formation. 
In this synthesis, the second building block C12-C15 was synthesized starting 
from the aldehyde 22, which was enantioselectively allylated with allyltributyltin 
and subsequently acetylated to give the compound 23 (see Scheme 3). 
Thereafter this compound was dihydroxylated and after glycol cleavage 
transformed to the vinyl iodide 24 by Wittig reaction. The product 24 was an 
analogue to the above described compound 21 and had an additional methyl group 
at C12, necessary for the synthesis of epothilone B. 
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 Scheme 3. Synthesis of Vinylolefin 24 as an Intermediate for the Suzuki 
Coupling 
 
 
In assembling both fragments, a regiospecific Suzuki coupling allowed the 
union of intermediates 15 and 21 for epothilone A or 15 and 24 for epothilone B 
to form after an acetal cleavage compound 25 or 26, respectively (see  Scheme 4). 
These intermediates underwent a stereoselective ring closure through an 
intramolecular aldol reaction to give the desired macrocycles 27 with yield of 
51% (stereoselectivity ca. 6:1) and 28 with yield of 64% (stereoselectivity ca. 
3:2), respectively. Subsequent functional group transformations led to the desoxy 
precursor’s epothilone C and D, and finally after stereoselective epoxidation the 
epothilones A and B were obtained. 
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Scheme 4. Suzuki Coupling and Macroaldolization Reaction for the Preparation 
of   Epothilone A and B. 
 
The already mentioned olefin metathesis strategy to obtain epothilone B 
starts also from the key building block 13 (see Scheme 5). After removing of the 
benzyl group the hydroxy moiety was oxidized to obtain an aldehyde, which is the   
starting material for the chain elongation. In this way aldehyde 29 was 
synthesized in several steps. Coupling of 23 with aldehyde 29 via aldol addition 
results in diene 30.  
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After several modifications the ring was closed through an olefin 
metathesis reaction and the macrocycle 31 obtained.  For the olefin metathesis 
the molybdenum-based Schrock catalyst was used.[44] In this case, however, the 
C12-C13 double bond was formed as a mixture of Z:E isomers in an 
approximately 1:1 ratio. After cleavage of the protecting groups, epothilone D 
was obtained and final stereoselective epoxidation led to epothilone B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5. Synthesis of Epothilone B through an Olefin Metathesis Approach 
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Due to the low stereoselectivity in the olefin metathesis approach, as well 
as the poor yields in the case of the macrocyclization-aldol reaction, there was a 
lot of pressure in  establishing  alternative methods for ring  closure.[44] The third 
route established by Danishefsky et al. was the macrolactonization strategy. For 
that purpose compound 32 was synthesized (see Scheme 6). The most remarkable 
part of this route was the subsequent regio- and stereoselective Noyori reduction 
[46]
 of the keto moiety at C3 to obtain hydroxyl ester 33. This was carried out by 
the use of a ruthenium-binaphtol-complex as a catalyst under a hydrogen pressure 
of 85 atm. The stereoselectivity was higher than 95%. From compound 33, the 
epothilones were prepared in several steps including the macrolactonization 
reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6. Regio and Stereoselective Noyori Reduction 
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1.4.2. The Nicolaou Strategies to Epothilones 
 
OH
XS
N
HOOC
OOH
Y
R
O
Olefin Methathesis
Aldol reactionEsterification
35
32
38
 
 
Ring Closing Target Molecule 
Olefin-Metathesis Epothilone A    R = H, X = CH2, Y = CH2 
Macrolactonization Epothilone A    R = H, X = PPh3, Y = O 
Epothilone B    R = Me, X = PPh3, Y = O 
 
Figure 8.  Strategic Bond Disconnections applied in the Total Synthesis of the 
Epothilones 
 
In the field of epothilone synthesis K. C. Nicolaou and co-workers 
have done remarkable work. The special merits of Nicolaou et al. were to establish 
different synthetic routes  not  only  to  the  known  natural  epothilones  A-F,  but  
also to a large number of epothilone analogues. The group carried out experiments 
on solid phase synthesis for the construction of epothilone libraries. [47] 
Through combinatorial methods it was possible to synthesize different single 
fragments, which were used later for the formation of the macrocycles. The 
synthesis of a large number of epothilone derivatives allowed the investigation 
and understanding of the relationships between structure and biological activity.  
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Amongst many strategies, Nicolaou et al. considered  the  olefin  
metathesis approach[48]  for  constructing  the  macrocycle  and  simultaneously 
applied as well a second strategy based on macrolactonization [39,47]. Both 
methods were similar to that presented in the work of Danishefsky et al.. The 
first total synthesis in Nicolaou’s group led to epothilone A and its desoxy 
precursor epothilone C employing the olefin metathesis strategy (see Figure 8). 
The retrosynthetic analysis divides the target into three key building  
blocks, which were synthesized independently, following divergent synthetic 
pathways to Danishefsky et al.. The C7-C12 building block 35 was obtained 
starting  from  N-propionyl  bornyl  sulfonamide  33,  which  was  alkylated  with  
ω-iodo-pentene and the resulting product was subsequently reduced to alcohol 34 
by cleavage of  the bornyl  sulfonamide  residue (see  Scheme 7).  Further oxidation 
with N-methylmorpholine-N-oxide and tetra propylammoniumperruthenate led to 
aldehyde 35. The synthesis of the C1-C6 fragment 38 began with the 
stereoselective allylation of the keto aldehyde 36 using the Brown reagent 
allylisopinocamphenylborane. The newly-formed hydroxy moiety was 
protected with a silyl group and provided 37. An oxidative degradation of the 
double bound to a carboxyl group gave the desired product 38. The thiazol-
fragment 41 was synthesized starting from the carboxylic ester 39, which was 
reduced with diisobutylaluminium hydride to the corresponding aldehyde. 
Subsequent Wittig olefination gave the aldehyde 40, which was further 
transformed through a allylation[49] to the compound 41. 
The two fragments 35 and 38 were combined through an aldol 
condensation with lithiumdiisopropyl amide (LDA) to form the acid 42, which 
through an esterification with the thiazol alcohol 43 gave the starting material 45 
for the olefin metathesis reaction for the final stages of macrocycle generation (see 
Scheme 8). For the ring closing metathesis (RCM), Nicolaou et al. used the Grubbs 
catalyst [RuCl2(=CHPh)(PCy3)2].[50]  
Thereafter, similar to the  methods  established  by  Danishefsky  et  al.,  
the  double  bound  of  the  desoxy precursor epothilone C was stereoselectively 
oxidized to the epoxide, giving the end product, in this case epothilone A. 
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A series of oxidants were tested: (3,3-dimethyldioxirane), (3,3-methyl 
(triflouromethyl)-dioxirane) and (m-chloroperbenzoic acid) were used for the 
stereoselective oxidation, yielding epothilone A in 65% (de 3:1), 75% (5:1) and 48% 
(3:1) respectively. 
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Scheme 7. Synthesis of the Key Fragment for the Olefin Metathesis Approach of               
                  Nicolaou et al. 
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Scheme 8. The Preparation of Epothilones A via Aldol Reaction and Olefin 
Metathesis 
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A short time after establishing the first strategy for the building of the 
ring system, Nicolaou and co-workers published their second route, which applied 
an Yamaguchi macrolactonization method [51] for the ring formation. They used 
this approach for the stereoselective synthesis of both epothilones A and B, the 
schemes 10 depicts the synthesis of epothilone B. The construction of the carbon-
chain starts with the formation of the fragments C1-C6 (46) and C7-C15 (52), 
which were assembled through an aldol reaction with LDA to give the ring 
closure precursor 53. The first building block C1-C6 46 was synthesized starting 
from compound 37. 
After ozonolysis of olefin 37 followed by reduction to the corresponding 
alcohol, which was further protected, the key fragment C1-C6 46 was obtained. 
The homoallylic alcohol 41 for the formation at the C7-C15 building block was 
used as a starting material. In three steps, including an oxidation of the olefin, 41 
were transformed to the thiazol aldehyde 47 (Scheme 9). Thereafter, followed  a  
Z-selective  Wittig  reaction  with  the  ylide  48  which  lead  to  the  chain-
elongated  product  49. The ester function  was  reductively  removed  and  after  
a hydroboration  of  the  terminal  double  bond,  the  primary-formed  hydroxy 
function  was replaced  by  iodine  to  give  50.  Chain elongation with a stereo 
controlled introduction of the C8-Methyl, epothilone numbering, was 
achieved using an Enders alkylation with the SAMP-hydrazone 51.[52]  After 
oxidative cleavage of the chiral auxiliary group and subsequent reduction the 
desired key building block 52 was obtained. 
The aldol reaction was utilized for formation of compound 53 establishing 
the new stereocenters at C7 and C6 occurs with a stereoselectivity of approximately 
3:1 (Scheme 10). Thereafter  the  ring  closure  precursor  53  was  transformed  in  
several  steps  to  the carboxylic  acid  54.   
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The macrolactonization was carried out using the Yamaguchi procedure. 
After cleavage of the silyl protecting groups in 55 the desoxy precursor epothilone 
D was isolated. The end-product, EPO B, was obtained using a stereoselective 
epoxidation (de 5:1). 
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Scheme 9. Preparation of The C7-C15 Fragment 52 for Further Synthesis of   
                  Epothilone B 
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Scheme 10. Ring Formation via Yamaguchi Macrolactonization 
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1.4.2. The Schinzer Strategies to Epothilones 
 
 
OH
S
N
OO
Y
Aldol reactionEsterification
R1
O
O
n
X
R2Olefin Methathesis
35
41
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Ring Closing Target Molecule 
Olefin Metathesis - Epoxidation Epothilone A R1 = H, R2 = H, X = H,Y = CH2, n = 3 
Epothilone B R1 = H, R2 = CH3, X = H,Y = CH2, n = 3 
Macrolactonization Epothilone B R1 = CH3, R2 = H, X = I,Y = I, n = 1 
 
 
Figure 9.  The Schinzer et al. Strategic Bond Disconections and Retrosynthetic 
Analysis for the Preparation of Epothilone A 
 
Another research group which made big contributions in the field of the 
epothilone synthesis is that of D. Schinzer. At the beginning of 1997, Schinzer et al.  
published their independently developed olefin metathesis approach to 
epothilones A and C.[40] Their design required three key intermediates 58, 35 
and 41, which were obtained by asymmetric synthesis (see figure 9). 
Compounds 35 and 41 were also used in the total synthesis of Nicolaou et al..  
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The formation of the single (6R,7S) diastereomer in the aldol condensation 
of the ethyl ketone 58 with the aldehyde 35 via a lithium enolate was most 
impressive, and was attributed to the influence of the acetonide moiety. Attachment 
of the side-chain 41 (figure 9) by esterification, ring closure through olefin 
metathesis, and epoxidation with 3,3-dimethyldioxirane, led to the desired 
products epothilone C and A  respectively.  Like  Nicolaou  et  al.,  the  group  of  
Schinzer  also applied the Grubbs catalyst [RuCl2(=CHPh)(PCy3)2], for the ring 
closing metathesis reaction. 
In 1998, Schinzer et al. established another new synthetic route [53] to 
epothilone B using a macrolactonization strategy as a key reaction step for the 
ring formation. The most innovative steps in this synthesis are the successfully 
introduction of the correct chiralities at the stereocenters C3, C6 and C7 via 
stereoselective aldol reactions. The main key intermediates were the C1-C6 
fragment 58 and the C7-C15 fragment 66.  
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                 Scheme 11. Synthesis of C1-C6 Building Block 58 
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The synthesis of the C1-C6 fragment started from the α-bromoester 56, 
which was combined with pentane-3-one through a Reformatsky reaction giving ß-
hydroxyester as intermediate (see Scheme 11). After subsequent reduction and 
oxidation the coupling product was transformed to the appropriate aldehyde 57. 
Thereafter a stereoselective aldol reaction with (S)-HYTRA [(S)-2-hydroxy-1,2,2-
triphenylethylacetate] followed according to the method of M. Braun et al.[54] 
introducing the correct chirality at C3. The condensation product was further 
reduced, the resulting 1,3-diol moiety was protected as an acetal and the double 
bound was oxidized to give the ketone 58. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12. Synthesis of Compound 65 
 
 
The alkyl zinc compound 65 contains the stereocenter C8 in the later 
macrocycle (see Scheme 12). The synthesis of 65 starts with the Evans 
auxiliary 67, which allowed the introduction of the correct chirality.[55] For that 
purpose, the Evans auxiliary 67 was alkylated in a stereoselective reaction with 
allyl iodide obtaining compound 68. The oxazolidinone group was cleaved by 
reduction with lithiumaluminium hydride and after protection of the resulting 
hydroxy moiety, the terminal double bond was reduced using a of borane-THF  
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complex, and then oxidized with iodine chloride and sodium acetate to the 
corresponding alkyliodide 69. Compound 69 was coupled with zinc copper 
mixture giving the alkyl zinc compound 65. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                        
 
 
 
 
 
Scheme 13. Synthesis of C7-C15 Building Block 66 
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The synthesis of the C7-C15 fragments begins with (S)-hydroxy succinic 
acid derivative 59, which after reduction and cleavage of the protecting group 
was transformed to the hydroxy butyrolactone 60 (see Scheme 13). After TBS 
protection of the hydroxy moiety, ring opening with methyl lithium to give the 
lactol and subsequent protection of the resulting hydroxyl group, the ketone 61 
was isolated. The thiazol-containing residue was introduced by a Wadsworth-
Emmons reaction with 62, and after deprotection of the chain-elongated product, 
the compound 63 was obtained. Dess-Martin oxidation and Wittig reaction gave 
the vinyl iodide 64 which was coupled with the alkyl zinc compound 65 in a 
palladium-catalyzed coupling. The resulting product was deprotected and 
oxidized to give the desired C7-C15 key fragment 66. The coupling reaction 
presented by Schinzer et al. appeared as an alternative to the Suzuki-cross 
coupling used by Danishefsky et al.. 
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Scheme 14. Aldol Reaction and Macrolactonization for Synthesis of Epothilone B 
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The compound 70 was formed via stereoselective Aldol reaction with LDA 
of the C7-C15 fragment 66 with the C1-C6 fragment 35 (see Scheme 14), 
introducing   the correct configurations at the C6 and C7 stereocenters. The high 
stereoselectivity (de 9:1) was reached via the strong chelating abilities of the 
C1-C6 fragment, reinforced by the acetal-protecting group. After cleavage of the 
acetal group the synthesis of epothilone B proceeded similar to the synthesis 
presented in the work of Nicolaou et al.. 
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Chapter 2 
 
Aims  
 
Since 1996 The Schinzer group has been working on the total synthesis of the 
epothilones. Although the group has been working on numerous epothilones and 
their derivatives, there are still some novel epothilone analogues to be 
synthesized. It has been predicted that some of these analogues show high activity 
against tumor cells and a unique mechanism of action as microtubule-stabilizing 
agents. Nevertheless, the epothilone pose a considerable challenge to the synthetic 
chemist and, most importantly, offered opportunities for the discovery and 
development of new synthetic technologies and strategies. The variations of the 
different functional groups in the natural molecule have made it possible to find 
an analogue with higher activity and or an improved process chemistry profile. 
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 Scheme 15. Retrosynthetic Analysis of 8,9 Dehydro Epothilone C 
Aims                                                                                                                       32                                                                                                               
 
The purpose of my project is the development of a new analogue of 
epothilone C with a double bond between the C8 – C9 atom carbon (see scheme 
15). Loose of the methyl group at position C8 resulted in considerable loss of 
biological activity, but still this compound is an interesting analogue for further 
investigation and until today this compound was unknown. The conformation of 
this analogue also fits very nicely in the pharmacophoric model of the active 
conformation of epothilone and tubulin. It could even increase the fit. Also this 
molecule posed new challenge for the synthetic methods developed by Schinzer et 
al. for the total synthesis of Epothilone A.  
 
This is a convergent synthetic route which is selective and flexible. Using 
the previous Schinzer et al. retrosynthetic methods for Epothilone A, the 
following retron are required (see scheme 15): 41, 58 and 88. For the novel 
olefinic aldehyde 88, the E configuration is necessary. 
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Chapter 3 
 
Results and Discussion  
 
3.1. Synthesis of (S)- Ethyl Ketone Fragments 58 
 
The retrosynthetic analysis relies on the late stage ozonolysis to install the ketone 
from an olefin and an aldol reaction to introduce the chirality. The olefinic 
aldehyde was constructed using a Reformatsky reaction, elimination and an 
oxidation adjustment sequence. 
 
O O O OH O
HO
O
O
Ph
OH
PhPh
+
O
58 68 66 67
 
Scheme 16. Retrosynthetic of (S)- Ethyl Ketone Fragments 58 
 
The construction of the stereocenter at C3 in the epothilone macrocycle was 
achieved by a diastereoselective aldol reaction with the chiral acetate equivalent 
(S)-(-)-HYTRA (1,1,2- triphenyl-1,2-ethanediol acetate) 66.  (S)-HYTRA was 
synthesized starting from (S)-(+)-Mandelic acid 63 by the method of Braun et al. 
in three steps (see scheme 17).[54] In the next steps the (S)-(+)-Mandelic acid 63 
was further transformed using catalytic acid in methanol to yield the ester 64 in 
91% yields, which was reacted with PhMgBr to give the diol 65. The primary 
alcohol 65, was then acylated to give the acetic anhydride 66 in the presence of 
catalytic amounts of scandium (III) triflate in 78% yield (Scheme 17).[56] This 
method is differs from that of Braun et al. who used acetiyl chloride in the 
presence of a pyridine catalyst.  
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The reason behind this change in the protocol was due to the fact that the 
aldol reaction between compound 66 and 57 failed. Our observation with Braun 
methode has been proved which are from 10 batch of the aldol reaction only one 
is succeeded. The procedure that we used is very simple by direct filtration of the 
reaction mixture avoiding the extensive drying necessary when using Braun`s 
methode, also the yields are comparable. 
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Scheme 17. Synthesis of (S)-HYTRA 66 
 
 
Aldehyde 57 required for the aldol reaction was obtained using a Reformatsky 
reaction between α–bromo ester and 3-pentanone which furnished β- hydroxyester 
60 in 65% yield.[57] Dehydration with P4O10 gave the olefinic ester (80%, only the 
E isomer was detected by 1H and 13C NMR spectroscopy), which then was 
converted to the aldehyde by a reduction with lithium aluminium hydride and 
subsequent Swern oxidation in 63% yields (scheme 18) respectively. 
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Scheme 18. Synthesis of Aldehyde 57 
 
 
Addition of the dianion of 66 to 57 with 2 eqv LDA in THF at -78◦C 
resulted in the formation of crystalline ester 67 in excellent diastereoselectivity 
(96% de, by HPLC) and good yield (75%). LiAH4 reduction allowed the auxiliary 
to be removed nearly quantitatively and led to the diol 68 in 90% yield with the 
recovery diol 65. Finally, 68 was protected using acetone and CuSO4 in presence 
of TsOH and pyridine as catalyst yielding the acetonide 69 in 90% yield. Finally, 
ozonolysis gave the desired ß-olefinic aldehyde 58 in 85% yield (scheme 19). 
 
 
 
 
 
Results and Discussion                                                                                          36   
 
O
O
Ph
H
Ph
Ph
OH
2 LDA,THF
O
O
O
Ph
H
Ph
Ph
OH
OH
LAH
Et2O OHOH
Aceton,
CuSO4,
cat. TsOH/Py
90%
OO
O3, CH2Cl2,
-780 C
PPh3
O OO
85%90%
66 57 67
68 69
58
-780 C
96% de
 
 
Scheme 19. Synthesis of (S)- Ethyl Ketone Fragment 58 
 
 
3.2. Synthesis of Thiazole Fragment 41  
 
The Thiazole building block 41 is derived from two key fragments:  Phosponate 
70 and methyl ketone 71 by means of Horner-Emmons reaction (see scheme 
below ).  
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Scheme 20. Retrosynthetic Analysis of Thiazol Fragment 41. 
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In the previous total synthesis of epothilone B [58], the stereocenter of the 
metyl ketone 71 had been established by a Sharpless resolution which gave 71 in 
80% ee (see scheme 13).  
 
HO
O
OH
OH
O
Cyclohexanone
BF3.H2O
HO
O O
O
O
BF3.SMe2,
THF/B(OMe)3
95% 92%
HO
O O
O
O
+
O
O
OH
TsOH (0.1 Eqv),
CH2Cl2
72%
over 2 steps
O
O
OH
O
O
OH
O
O
OTBS
O
OTBS
O
OTBS
TBSCl,
Imidazole MeLi, THF
-78oC
OH
OH
+
93%
TBSCl,
Imidazole
73%
OTBS
OTBS
O
over 2 steps
72 73
74 75
75 76 77 78
71
75
 
 
Scheme 21. Synthesis of Methyl Ketone 71 
 
In this sequence, (S)-Malic acid was chosen as the source of chirality. Its 
cyclohexylidine ketal 73 [59] was selectively reduced with BH3.Me2S. The alcohol 
product was cyclised into the known lactone 75 [60] by using 0.1 Eqv TsOH in  
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dichloromethane. Protection of compound 75 using a standard procedure afforded 
silyl ether 76 in 93% yield. Addition of MeLi gave the lactols 77 and 78 which 
were protected without purification as the TBS-ethers under standard conditions to 
give enantiomerically pure ketone 71 (73% yield over 2 steps). 
The phosphonate 70 which is required in the Horner-Emmons reaction with 
methyl ketone 71 was synthesized over 2 steps using the commercially available 
compounds: 1,3-Dichloroacetone 79 and thioacetamide 80 which were reacted 
under Hantzsch condition affording the 4-chloromethyl-2-methythiazole 81. An 
Arbuzov reaction then gave phosphonate 70 (see scheme 22). 
 
 
Cl
O
Cl +
CH3 NH2
S S
N Cl
S
N
P(OEt)2
O
EtOH,
97%
P(OEt)3,
82%
70
79 80 81
 
                   
Scheme 22. Synthesis of Phosphonate 70 
 
 
Deprotonation of phosphonate 70 with n-Buli and subsequent reaction 
with methyl ketone 71 under Horner-Emmons conditions (see scheme 23) yielded 
the desired trisubstituted olefin 82 as a single stereoisomer in good yield (79%). 
Selective desilylation of the primary hydroxyy group from 82 was achieved by the 
action of aqueous HF in MeCN/Et2O, leading to hydroxyl compound 83 in 90% 
yield. Dess-Martin oxidation then gave aldehyde 84 in 84% yield, which was 
converted to the required thiazole alcohol 41 by the action of the Wittig reagent 
Ph3P=CH2 and subsequent desilylation with TBAF in 84% yield over two steps. 
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Scheme 23. Synthesis of The Thiazol Fragments 41 
 
 
 
3.3. Synthesis of Aldehyde Fragment 88 
 
Aldehyde bulding block 88 was prepared by again employing an Horner-
Wadsworth-Emmons reaction using methoxide in the methanol as the base (see 
scheme 24).  
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Scheme 24. Retrosynthetic Analysis Aldehyde 88 
 
Thus, ester 86[62] was obtained from 4-Pentenal 85 and 
carbomethoxymethyl diethyl phosphonate (stabilzed phosphonate). This reaction 
proceeds in high stereoselectivity and delivers only the E isomer in 70%. The 
transtion state of this reaction favours only the formation of the 
thermodynamically more stable intermediates 1E which leads to the E-alkene (see 
scheme 25). The by-product dialkylphosphate salt was readily removed by 
aqueous extraction. Treatment of 86 with DIBAL-H afforded alcohol 87[63] in 
80% yield and via oxidation of compound 82 with Dess-Martin-Periodinane the 
pure aldehyde 88 with the desired E configuration was isolated in 65% yield.  
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Scheme 25. Synthesis of Aldehyde 88 
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3.4. Total synthesis of 8,9-dehydro Epothilone C 
 
The aldehyde 88 and ethyl ketone fragment 58 were reacted under aldol 
condition to produce the C1-C12 building block of the novel epothilone C 
analogue. The optimum conditions for this coupling reaction required the 
generation of the syn-lithium enolate of ethyl ketone 58 with 0.98 equivalents of 
LDA in THF at -78◦C, followed by the addition of aldehyde 88 (see scheme 17). 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 26. Aldol reaction of Fragment 88 and 58 
 
The procedure of aldol reaction for this compound had been introduced by 
Anja Limberg[64]. With aldehyde 88 it proceeds with moderate diastereoselectivity 
(3:1) in favor of the desired syn (6R,7S) isomer 89 in 60% yield (see scheme 26). 
The diastereoselectivity of this reaction was decreased compared to previous 
publications from Schinzer et al., due to the use of the achiral aldehyde (α,β- 
unsaturated olefin). The result just reflects the inherent selectivity of the enolate 
(scheme 26). The second chiral element in the aldehyde is missing and therefore 
no double stereoselection can be obtained. 
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The Aldol adduct 89 was protected with TBSOTf giving the silylether 90 
in 80% yield. Cleavage of acetonide 90 has been successful by modified 
procedure [64] using the lewis acid CeCl3.7H2O[65] with water (2:0.5) in acetonitrile 
under reflux instead of CSA in MeOH. The conditions yielded diol 91 in 78% 
yield and no cyclization by-product was detected. Before we discovered this 
combination of reagents, several methods were tested to cleave acetonide 
including using mixtures of HCl in MeOH, PPTS in MeOH, and p-TSOH in 
CH2Cl2 at -20◦C. All these methods failed to produce the desired compound 
leading only to decomposition (see table 1). This is probably due to the instability 
of this compound in the presence of acids in methanol. 
 
 
Table 1. Methods Test Conditions for the Cleavage of Acetonide 85 
 
 
Treating 91 with excess TBSOTf and 2,6 lutidine gave tris-silyl ether 97 
almost quantitatively (90%). Selective deprotection of the primary TBS ether, 92, 
was achieved by the action of mixture of HF complex and pyridine in THF 
leading to mono alcohol 93 in 70% yield. Finally, acid 94 was obtained from 93 
by oxidation with PDC in DMF in 69% yield (see scheme 27).[58] 
 
 
 
 
 
      Reagent, Condition                                               Results 
PPTS in MeOH, O◦C, 24 Hr Decomposition 
PPTS (0.2 Eqv) in MeOH, RT, 20 Hr Decomposition 
p-TsOH (0.2 Eqv)in CH2Cl2, -20 ◦C, 4 hr Decomposition 
1M HCl : MeOH (1:9), RT, 3 Hr Decomposition 
HCl :THF:H2O (0.5:1:2), RT, 2 Hr Decomposition 
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Scheme 27. Synthesis of Acids 94 
 
 
 
Table 2. Optimization Esterification of Fragment Acids 94 and Thiazole 41 
 
 
                Reaction  Conditions                                           
         (89:63: DCC/ EDCI: DMAP)                                       Results 
                               eqv 
1: 1: 1.3: 0.2 56 %  +  side product 
1: 1.2: 1.3: 0.2 57% + side Product 
1: 1: 1.3 (EDCI): 0.2 70% of ester 95 
1: 1.2: 1.3 (EDCI): 0.2 78 – 80% of ester 95 
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Initials attempts for the esterification of thiazole fragment 41 and acid 89 
with DCC and DMAP gave the desired diene 95 only in moderate yield (25-57%) 
and were not regularly reproducible. A significant improvement in the efficiency 
of the reaction could be realized, however, by drying of starting material, the use 
of EDCI instead of DCC and a 20% excess of the thiazole fragment 41. Thus 
under optimized conditions (1.0 eqv acid 94, 1.2 eqv alcohol 41, 1.3 eqv EDCI,  
0.3 eqv DMAP) ester 90 was consistently obtained in yields between 76 and 83% 
(see table 2).    
With diene 95 as metathesis precusor in hand, we successfully carried out 
the RCM olefin-metathesis reaction of 95 with Grubbs catalyst (first generation) 
(see scheme 28). The reaction provided 2 mixture 96 and 97 which could be 
separated under normal chromatography, the desired E (3J12,13 = 15.5) isomer 
being slightly favored with (Z/E = 3:1, based on % of the yield). These 
phenomena probably can be explained that the double bond in C8 and C9 with E-
geometric promotes a favorable conformation for the formation of E-isomer 
during the RCM reaction or increases the final thermodynamic stability of the E-
isomer versus the Z-isomer. 
The conversion of the fully protected macrolide 97 to our target structure 
98 then required the selective removal of the TBS protecting groups. This 
transformation could be achieved in moderate yield (50%) by treatment of 97 with 
excess amount of Et3N.(HF)3 in acetonitrile in the presence of 10% v/v 
triethylamine. [66]
 
 
 
 
 
 
 
 
 
 
 
Results and Discussion                                                                                          45   
 
(S)
OTBS O
(R) (S)
OTBSO
HO
89
S
N
OH
41
+
+
8,9 dehydro Epothilone C
EDCI, DMAP
CH2Cl2
Grubs Catalyst 1st
       6 mol %
CH2Cl2, RT, 24 hr
95
96 97
 excess Et3N.(HF)3
10 % v/v Et3N
68%
1:3
HN
O OOTBS
OTBS
S
N
O
O
O OTBS
OTBSS
N
O
O
O OH
OHS
N
O
O OOTBS
OTBS
S
N
       98 
 
Scheme 28. Ring Closing Methatesis of 8,9-dehydro Epothilone C 
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Chapter 4  
 
Summary 
 
The purpose of this project was the development of a new analogue of 
epothilone C with a double bond between the C8 – C9 carbon atom. Herein a 
novel synthesis of 8,9-dehydro epothilone C was described (scheme 28). A 
convergent synthetic route which was stereoselective, robust and quite flexible 
was employed. The construction of the stereocenter at C3 in the epothilone 
macrocycle is achieved by a diastereoselective aldol reaction with the chiral 
acetate equivalent (S)-(-)-HYTRA (1,1,2- triphenyl-1,2-ethanediol acetate) 66. 
Due to the fact that the aldol reaction between compound 66 and 57 failed, we 
were developed a new protocol by employing catalytic amounts of scandium (III) 
triflate instead of acetiyl chloride in presence of a pyridine catalyst used by Braun 
et al..  
Aldehyde bulding block 88 was obtained from 4-pentenal 85 by employing 
a Horner-Wadsworth-Emmons reaction using methoxide in the methanol as the 
base. This reaction delivers only the E isomer in 75% yield (scheme 29). 
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Scheme 29. Synthesis of Aldehyde 88 
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The aldol reaction of aldehyde 88 and ethyl ketone 58 (for building the C1-
C12 fragment of epothilone) are giving moderate diastereoselectivity (3:1) in favor 
of the desired syn (6R,7S) isomer 89 in 60% yield (scheme 30).  
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Scheme 30. Aldol Reaction of Aldehyde 88 and Ketone 58 
 
After protection of secondary alcohol 89, subsequent cleavage of acetonide 
with CeCl3.7H2O the intermediate 92 as isolated. Deprotection of the primary 
TBS group and oxidation of the alcohol with PDC in DMF to yield acid 89 (69%) 
(see scheme 31).  
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Scheme 31. Synthesis of Acids 89 
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The esterification reaction of thiazole fragment 41 with acid 89 has been 
successfully in good yield by the use of EDCI instead of DCC and a 20% excess 
of the thiazole fragment 63.  
 
(S)
OTBSO
(R) (S)
OTBSO
HO
89
S
N
OH
41
+ EDCI, DMAP
CH2Cl2
O
O OOTBS
OTBS
S
N
95
 
Scheme 32. Synthesis of Diene 95 
 
At the end, we successfully carried out the RCM olefin-metathesis reaction 
of 95 with Grubbs catalyst (first generation) giving the mixture of macrolide 96 
and 97 which was separable under standard chromatography. Finally, a global 
deprotection of marolide 96/97 proceeded by employing a much milder desylation 
reagent, Et3N.(HF)3. The desired E (98) isomer is being slightly favored. 
 
 
1. Grubs Catalyst 1st
     6 mol %
CH2Cl2, RT, 24 hr
68%
95 98
2. Et3N. (HF)3
50%O
O OOTBS
OTBS
S
N
O
O
O OH
OHS
N
 
 
Scheme 33. Ring Closing Metathesis of 8,9-dehydro Epothilone C. 
 
In summary, the Schinzer et al. synthetic strategy offers the possibility to 
synthesize a new epothilone analogue with good overall selectivity. 
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Chapter 5  
 
Experimental Part 
 
5.1.1. Chemicals and Working Technique  
 
All  required  fine  chemicals  were  received  from  the  firms  ACROS ,  ALDRICH 
, FLUKA and MERCK. 4-Pentenal that has been used for aldehyde 88 precursor was 
purchased form Alfa Aesar in 97% purity.  They were used directly without further 
purification if nothing else was mentioned. All solvents were distilled and/or dried 
before use. Anhydrous solvents were obtained as follows: THF, diethyl ether and 
toluene by distillation from sodium and benzophenone; dichloromethane and 
chloroform. Unless mentioned, all the reactions were carried out under a nitrogen 
atmosphere and the glass material was pre-dried by flame drying under high vacuum 
(oil pump RV 5, EDWARDS). All the chemicals, which were air or water sensitive, 
were stored under inert atmosphere. Compounds  which  are  not  described  in  the  
experimental  part,  were  prepared according to the literature.[40,53,58] 
 
5.1.2 NMR-Spectroscopy  
 
1H , 13C NMR and two-dimensional spectra (COSY, TOCSY, HSQC, HMBC, 
NOESY) were measured on BRUKER DPX 400, AMX 200, AMX 400 and 
BRUKER AMX 600 (600 or 150 MHz, respectively). As solvents was used 
chloroform-d or benzene-d6. TMS (δ = 0) was used as an internal standard. Data are 
reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet,  
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m =multiplet, br = broadened), coupling constant (Hz), integration, peak assignment]. 
For the 13C NMR spectra the signal multiplicity is determined by means of the APT 
or DEPT-135 technique: d for CH, q for CH3, t for CH2, and s for C. 
 
5.1.3. Mass Spectrometry 
 
Mass spectra were recorded on a Finnigan SSQ 7000 from the FINNIGAN-MAT 
(Bremen).  High-resolution mass spectra were measured on an Intectra Finnigan 
MAT-95 mass spectrometer from the same firm. The used mass spectrometric 
ionization methods were electron-impact (EI) with 70eV ionization potential, chemical 
ionization (CI) with NH3 as gas reactant, fast-atom bombardment (FAB) or field-
desorption (FD). Significant fragments are reported as follows: m/z (relative 
intensity). 
 
5.1.4. Infrared Spectroscopy  
 
Infrared spectra (IR) were recorded on a FT-IR-2000 from the firm PERKIN ELMER. 
The percent transmittance (T%) of liquid or  oily  substances  was  measured  in  film  
between  potassium  bromide  tablets.  Solid substances were pulverized with 
potassium bromide and percent reflection (R%) was measured. Absorption band 
frequencies are reported in cm-1.  
 
5.1.5. Polarimetry  
 
Optical rotations were measured on a Perkin-Elmer Polarimeter P-341. They are 
reported as follows: [ ] eTemperaturDα  (concentration, solvent). The unit of c is g/100 ml. As a 
solvent was used anhydrous CH2Cl2. 
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5.1.6 Melting Points  
 
Melting points were taken with a BÜCHI B-540 point microscope apparatus or 
digital Electrothermal IA 9100 from Kleinfeld firma and were not corrected. 
 
5.1.7. Elemental Analysis  
 
Elemental analyses were recorded with a LECO CHNS-932. 
 
5.1.8 Chromatographic Methods  
 
Analytical thin-layer chromatography (TLC) was performed on pre-coated silica gel 60  
F254 plates (MERCK) or POLYGRAM SIL G/UV254 (MACHEREY-NAGEL), and  pre-
coated aluminum oxide ALOX N/UV254 (MACHEREY-NAGEL). The compounds 
were visualized by UV254 light and the chromatography plates were developed with 
a vanillin solution or aqueous solution of potassium permanganate (heating on a hot-
plate).  For  preparation  of  the  vanillin  solution  were used 8.6 g  vanillin  dissolved 
in 200 ml ethanol  and put 2.5 ml H2SO4. The potassium permanganate solution was 
prepared from 2.5 g KMnO4 and 12.5 g Na2CO3 in 250 ml H2O and 5 ml 5%NaOH. 
Flash column chromatography was performed using flash silica gel 60 M (40-63 µm) 
from the firm FLUKA. 
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5.1.9. Synthesis of (S)-Ethyl Ketone Fragments 58 
 
(S)-(-)-2-Hydroxy-1,2,2-triphenylethyl acetate [(S)-HYTRA] (66): 
 
 
O
HPh
Ph
Ph
OH
O
1
2
 
66 
 
To a stirred solution of (S)-(-)-1,1,2-triphenyl-1,2-ethanediol 58 (35.0 g, 0.121 mol, 
prepared by braun methode and acetic anhydride (17.1 mL, 0.181 mol, 1.5 eq) in 
anhydrous acetonitrile (500 mL, at room temperature under nitrogen is added a 
solution of scandium (III) trifluoromethanesulfonate (1.23 g, 2.5 mmol, 2 mol%) ; 
The order of addition of the reagents has a significant effect on the yield of the 
reaction. The optimal order of addition of reagents is described above i.e., addition of 
Sc[III](OTf)3 slowly, last. Continual addition of the scandium (III) triflate during the 
course of the reaction maintained the pace of the process. Bolus addition of the 
catalyst resulted in a reaction that slowed down or stopped part way, resulting in 
lower yields; in anhydrous acetonitrile (125 mL) over approximately 35 min. After 
about 8 min a white precipitate begins to appear, and the resulting mixture is stirred at 
room temperature under nitrogen for a total of 3 hr. The solid is filtered, washed with 
acetonitrile (2 × 25 mL), and dried under vacuum at 40°C overnight to afford (S)-(-)-
2-hydroxy-1,2,2-triphenylethyl acetate 66 (31.36 g, 78%) as a white solid. 
 
General data: C22H20O3, MW: 332.39, mp 225-230°C (crude product). [ ]20Dα  = -196° 
(pyridine, crude product, c = 1); DC: Rf = 0.40 (Pentan/Et2O 2:1), UV (+), vanillin: 
yellow 
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1H NMR (CDCl3, 300 MHz) δ: 1.98 (s, 3 H, CH3CO2CH), 2.80 (s, 1 H, Ph2COH), 
6.66 (s, 1 H, PhCH), 7.04-7.42 (m, 13 H, Harom), 7.55-7.57 (m, 2 H, Harom) ;  
 
13C NMR (CDCl3, 125 MHz) δ: 21.1 (q, CH3CO2CH), 78.5 (d, PhCh), 80.3 (s, Ph2C), 
126.2 (d, Ph-2), 126.3 (d, Ph-3), 127.0 (d, Ph-4), 127.3 (d, Ph-4), 127.5 (d, Ph-2), 
127.8 (d, Ph-3), 127.9 (d, Ph-4), 128.4 (d, Ph-2), 128.5 (d, Ph-3), 135.9 (s, Ph-1), 
142.7 (s, Ph-1), 144.8 (s, Ph-1) , 169.7 (s, CH3CO2CH).  
 
IR (CHCl3) cm−1: 3064, 3024, 1737, 1495, 1372, 1239, 1168, 779;  
 
HRMS calcd for C22H19O2 ([M+H+]-H2O), m/z 315.1385,  
                    found 315.1386 
 
 
 
Ethyl 3-ethyl-3-hydroxy-2,2-dimethylpentanoate (60): 
 
EtO
O
OH
1 2 3
4
4`
5`
5
 
 
60 
 
A suspension of zinc dust  (10.79 g,  0.165 mol)  in  THF  (40 mL)  and  B(OMe)3   
(40 mL)  was activated  with 1,2-dibromoethane (0.26 mL, 3.0 mmol)  and  TESOTf  
(0.34 mL, 1.5 mmol). A mixture of 3-pentanone (15.9 mL, 0.15 mmol) and ethyl 2-
bromo-2-methylpropanoate (23.4 mL, 0.165 mol) was added slowly to the activated  
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zinc suspension. The reaction mixture was heated gently in a hot air stream until the 
reaction started. The addition was performed at such a rate that the mixture gently 
refluxed. After addition of the  reactants,  the  mixture  was  refluxed  for 2 h  and  
stirred  at  room temperature for  20 h. The reaction was quenched by addition of 25 
% aqueous NH3 solution (45 mL) at 0◦C. Glycerine (45 mL) and Et2O (40 mL) were 
added and the organic layer was separated. The aqueous layer was extracted with 
Et2O (3 mL). The combined organic layers were dried over MgSO4 and concentrated 
in vacuo. Purification of the residue by vacuum distillation afforded β-hydroxy ester 
60 (19.72 g, 65 %) as a colorless liquid. 
 
General Data: C11H22O3, MW: 209.29.: bp: 108-110◦C (10 mbar); DC: Rf = 0.48 
(Pentan/Et2O 1:1), UV (-), Vanillin: dark blue 
 
1H NMR (400 MHz, CDCl3): δ = 4.17  (q,  3J = 7.1 Hz,  2 H, CH3CH2OCO),  3.78  (s, 
1 H, OH), 1.56 (m, 4 H, H-4), 1.29 (t, 3J = 7.1 Hz, 3 H, CH3CH2OCO), 1.22  
(s, 6 H,  C2-CH3),  0.93  (t,  3J = 7.5 Hz,  6 H,  H-5) ;   
 
13C NMR (100 MHz, CDCl3): δ = 179.2 (s, C-1), 76.2 (s, C-3), 60.9 (t, 
CH3CH2OCO), 50.3 (s, C-2), 28.2 (t, C-4, C-4`), 21.6 (q, C-5, C-5`), 14.1 (q, 
CH3CH2OCO), 8.9 (q, C2-(CH3)2);  
 
MS (PCI, CH4): m/z (%): 203.4 (100) [M+H]+, 185.4 (78) [M+H - H2O]+ , 171.1 (11), 
155.1 (23), 145.1 (24),111.1 (16) ; C11H22O3  (202.3):  
 
HRMS calcd  : C 65.31, H 10.96  
            found : C 65.09, H 11.35. 
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Ethyl -(E)-3-ethyl-2,2-dimethyl-3-pentenoate (61): 
 
1 2 3
4
5
EtO
O
1`
2`
 
61 
 
Hydroxy ester 60 (9.74 g, 48.1 mmol) was heated under reflux with Sicapent (11.84 
g) in cyclo-hexane (40 mL) for 20 min. The solvent was removed by distillation. 
Vacuum distillation of the residue afforded ester 61 (7.10 g, 80 %) as a colorles 
liquid. 
 
General Data: C11H20O, MW: 184.28; bp: 60-63◦C (3 mbar); DC: Rf = 0.75 
(Pentan/Et2O 2:1), UV (-), Vanillin: pale blue. 
 
1H NMR (400 MHz, CDCl3): δ= 5.41 (q, 3J = 6.8 Hz, 1 H, H-4), 4.11 (q, 3J = 7.2 Hz, 
2 H, CH3CH2OCO), 2.06 (q, 3J = 7.6 Hz, 2 H, CH3CH2C=C), 1.65 (d, 3J = 6.8 Hz, 3 
H, H-5), 1.28(s,6 H, C2-CH3),  1.23  (t,  3J =7.1 Hz,  3 H,  CH3CH2OCO),  0.97  (t,  3J 
=7.5 Hz, 3 H, CH3CH2C=C) ;  
 
13C NMR (100 MHz, CDCl3): δ = 177.2 (s, C-1), 144.1 (s, C-3), 118.5 (d, C-4), 60.3 
(t, CH3CH2OCO), 48.4 (s, C-2), 24.9 (q, C2-(CH3)2), 21.7 (t, C-1`), 14.1, 13.9,13.5 
(q, C-5, CH3CH2OCO, C-1`) ;  
 
MS (PCI, CH4): m/z (%): 185.1 (69) [M+H]+, 169.1 (14), 157.1 (100), 153.0 (16), 
139.0 (9), 124.9 (15), 111.0(30), 57.0 (38) ;  
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HRMS (EI): calcd for C11H20O2  184.1463, 
                     found 184.146. 
 
 
(E)-3-Ethyl-2,2-dimethyl-3-pentenal (62): 
 
1 2 3
4
5
1`
2`
HO
 
62 
 
LAH  (2.95 g, 77.6 mmol, 2.0 equiv) was added to a solution of ester 7 (7.15 g, 38.8 
mmol) in THF (40 mL). The mixture was refluxed for 2 h. After cooling to 0◦C, Et2O 
(30 mL) was added, and the mixture was quenched by dropwise addition of  
water (2.95 mL), 15% aqueous NaOH (2.95 mL), and water (4.50 mL). Celite (400 
mg) was added, and the mixture was stirred for 30 min at room  
temperature. The precipitate was filtered off by suction and washed with  
Et2O (4 x 40 mL).  The  filtrate  and  the  washings  were  combined  and 
concentrated in vacuo to furnish crude (E)-3-ethyl-2,2-dimethyl-3-penten-1-ol as a 
colorless liquid, which was used for the preparation of aldehyde 57 without  further  
purification. An analytical sample of the alcohol was obtained by vacuum distillation. 
 
General Data: C9H18O, MW: 142.24; bp: 105-106◦C (30 mbar); DC: Rf = 0.40 
(Pentan/Et2O 5:1), UV (-), Vanillin : dark blue. 
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1H NMR (400 MHz, CDCl3): δ = 5.43 (q, 3J = 6.7 Hz, 1 H, H-4), 3.35 (s, 2 H, H-1),  
2.07 (q, 3J = 7.6 Hz, 2 H, CH3CH2C=C), 1.67 (d, 3J = 6.7 Hz, 3 H, H-5), 1.34 (brs,1 
H, OH), 1.04 (s, 6 H, C2-CH3), 1.00 (t,3J = 7.5 Hz, 3 H, CH3CH2C=C) ;  
 
13C NMR (100 MHz, CDCl3): δ = 145.2 (s. C-3), 120.5 (d, C-4), 69.7, 42.0 (s, C-2), 
24.0 (q, C2-CH3), 20.0 (t, C-1`), 14.2, 13.6 (q, C-5, C-2´).  
 
MS (70 eV, EI): m/z (%): 142.1 (7) [M]+ , 125.1 (48), 111.0 (34),  96.2 (14), 83.0 
(35), 71.1 (37), 69.1 (100), 57.0 (42), 55.0 (66). 
 
 
 
(E)-3-Ethyl-2,2-dimethyl-3-pentenal (57):  
 
 
O
1 2 3
4
5
1`
2`
 
57 
 
DMSO  (6.59 mL,  93.0 mmol,  2.0 equiv)  in  CH2Cl2   (20 mL)  was  added  
dropwise at -78◦C to a stirred solution of (COCl)2  (3.71 mL, 42.7 mmol, 1.1 equiv) in 
CH2Cl2 (97 mL) within  5 min. The mixture was stirred for 10 min at -78◦C. The 
crude (E)-3-ethyl-2,2-dimethyl-3-penten-1-ol dissolved in CH2Cl2  (38 mL) was 
added dropwise within 5 min. The mixture was then stirred for 1 h at -78◦C. The 
reaction was quenched by dropwise addition of NEt3 (27 mL, 194.0 mmol, 5.0 equiv).  
The mixture was warmed to room temperature within 45 min. Water (97 mL) was 
added, and the mixture was stirred for 10 min. The organic layer was separated and  
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the aqueous layer was extracted with CH2Cl2 (3x100 mL). The combined organic 
extracts were dried over MgSO4 and concentrated in vacuo. Purification of the 
residue by vacuum distillation afforded aldehyde 57 (3.43 g, 65 % over two steps) as 
a colorless liquid. 
 
General Data: C9H16O, MW: 140.22; bp: 85-86 ◦C (28 mbar); DC: Rf= 0.75 
(Penta/Et2O 5:1), UV (-), Vanillin: dark blue. 
 
1H NMR (400 MHz, CDCl3): δ =9.27 (s, 1 H, H-1), 5.41 (q, 3J =6.8 Hz, 1 H, H-4), 
2.02 (q, 3J =7.6 Hz, 2 H, CH3CH2C=C), 1.69 (d, 3J = 6.9 Hz, 3 H, H-5), 1.17 (s, 6 H ; 
C2-CH3), 0.96 (t, 3J = 7.6 Hz, 3 H, CH3CH2C=C) ;  
 
13C NMR (100 MHz, CDCl3): δ = 203.5 (s, C-1), 141.4 (s, C-3), 122.6 (d, C-4), 
52.7 (s, C-2), 24.2 (t, C-1`), 14.1, 13.8 (q, C-5, C-2`) ;  
 
MS (PCI, CH4): m/z (%): 141.0 (29) [M+H]+ , 127.1 (98), 111.1 (100), 97.1 (2), 
83.1 (3) ;  
 
HRMS (EI): calcd for C9H16O 140.1201,  
                     found 140.116 
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(1S)-2-Hydroxy-1,2,2-triphenylethyl (3S,5E)-5-ethyl-3-hydroxy-4,4-di-methyl-5-
heptenoate (67): 
 
 
O
O
Ph
H
Ph
Ph
OH
OH
1
2
3 4 5
6
7
1'
2'
 
67 
 
 
nBuLi  (3.20 mL,  8.0 mmol,  2.5 m  solution  in hexanes) was added at  -78 ◦C to a 
solution of diisopropylamine (1.28 mL, 8.0 mmol) in THF (10 mL) cooled to-78 ◦C. 
This LDA solution was stirred for 30 min at 0 8C and added dropwise to a solution of 
(S)-(-)-2-hydroxy-1,2,2-triphenyl acetate 66 (1.330 g, 4.0 mmol) in THF (25 mL) at -
78◦C. The mixture was stirred for 1 h at 0◦C. The resulting orange-red solution  
was cooled to 78 ◦C, and a solution of aldehyde 57 (673 mg, 4.8 mmol,  
1.2 equiv) in THF (5.0 mL) was added dropwise. The mixture was stirred  
for 90 min. The reaction was quenched with saturated aqueous NH4Cl solution (30 
mL). The organic layer was separated and the aqueous layer was extracted with 
CH2Cl2 (3 x 50 mL). The combined organic extracts were dried over MgSO4 and 
concentrated in vacuo. Purification of the residue by flash chromatography 
(pentane/Et2O 3:1) afforded β-hydroxy ester 67 (1.41 g, 75 %, 94 % de) as a colorless 
crystalline solids. 
 
General Data: C31H36O4, MW: 472.62; bp: 144-145 ◦C; [ ]20Dα  = - 252.5 (c = 1.0, 
CHCl3); DC: Rf = 0.43 (Pentan/Et2O 2:1), UV (+), Vanillin: green. 
 
 
 
 
Experimental Part                                                                                                       60 
 
1H NMR (400 MHz, CDCl3): δ = 7.59 - 7.54 (m, 2H, Harom.), 7.38 - 7.02 (m,  
13H, Harom.), 6.70 (s, 1 H, PhCH), 5.30 (q, 3J = 6.8 Hz, 1H,  H-6), 3.78 (ddd,  
3J = 10.0 Hz, 3J = 2.7 Hz, 3J = 2.5 Hz, 1H,  H-3), 2.86 (s, 1H,  Ph2COH), 2.31  
(dd, 2J = 15.7 Hz, 3J = 2.2 Hz, 1H, H-2), 2.21 (dd, 2J = 15.7 Hz, 3J = 10.0 Hz,  
1 H, H-2),  2.03  (d,  3J = 3.1 Hz,  1H, C3-OH),  1.98  (dq,  4J = 2.2 Hz,  3J =  
7.5 Hz, 2H, CH3CH2C=C), 1.60 (d, 3J = 6.8 Hz, 3H, H-7), 0.98, 0.91 (2 s, 2  
3H, C2-CH3), 0.91 (t, 3J = 7.6 Hz, 3H, CH3CH2C=C) ;  
 
13C NMR (100 MHz, CDCl3): δ = 172.2 (s, C-1), 146.0, 144.7 (s, Ph-1), 142.6 (s, C-
5), 135.6 (s, Ph-1), 128.4, 128.3 (d, Ph-2, Ph-3), 128.0 (d, Ph-4), 127.8, 127.5 (d, Ph-
2, Ph-3), 127.3, 127.1 (d, Ph-4), 126.3, 126.2 (d, Ph-2, Ph-3), 120.3 (d, C-6), 80.4 (s, 
Ph2C), 78.9 (d, PhCH), 72.3 (d, C-30), 44.0 (s, C-4), 37.4 (t, C-2), 22.9 (q, C4-CH3), 
21.3 (q, C4-CH3), 20.2 (t, C-1`), 14.3, 13.6 (q, C-7, C-2’) .  
 
MS (70eV, EI): m/z (%): 472.3 (<0.4) [M]+, 455.2 (0.4), 290.3  
(4), 273.1 (70), 256.1 (12), 195.1 (17), 183.1 (100), 167.2 (12), 112.0 (16),  
105.0 (26), 69.2 (10) ;  
 
HRMS (EI) : calcd C 78.78, H 7.68 ;  
                      found C 78.87,H 7.73. 
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(3S,5E)-5-Ethyl-4,4-dimethyl-5-heptene-1,3-diol (68) 
 
1
2
3 4 5
6
7
1'
2'
OHOH
 
 
68 
 
LAH (1.325 g,35.0 mmol,  7.0 equiv) was added portionwise to a refluxing solution 
of ester 67 (2.364 g, 5.0 mmol)  in  Et2O  (50 mL)  within  a  period  of  2 h. 
Refluxing was continued for 30 min. After cooling to 0◦C, the reaction was quenched 
by dropwise addition of water (1.35 mL) and 15 % aqueous NaOH  (1.35 mL). Et2O 
(40 mL) and water (1.35 mL) were added. The mixture was stirred for 1 h at room 
temperature until a white precipitate formed which was filtered off by suction through 
a small plug of celite. The precipitate was washed with Et2O (4 x  40 mL). The 
filtrate and washings were combined and concentrated in vacuo. Purification of the 
residue by flash  chromatography (pentane/Et2O 2 :1) afforded (S)-2,2,1-triphenyl-
ethane-1,2-diol 65  (912 mg,  90 %)  as  a  colorless  crystalline  solid,  and alcohol 68 
(836 mg, 90 %) as a colorless oil. 
 
1H NMR (400 MHz, CDCl3): δ = 5.43 (q, 3J = 6.8 Hz, 1 H ;  
H-6), 3.86 - 3.76 (m, 2H, H-1), 3.68 (dd, 3J = 10.3 Hz, 3J = 2.1 Hz, 1H, H-3), 3.00 
(brs, 1H, OH), 2.20 (br s, 1H, OH), 2.17 - 2.02 (m, 2H, CH3CH2C=C),1.67 (d, 3J = 
6.8 Hz, 3H, H-7), 1.71 - 1.52 (m, 2H, H-2), 1.03, 1.01 (2 s, 2x3H, C4-CH3), 0.91 (t, 3J 
= 7.6 Hz, 3H, CH3CH2C=C). 
 
General Data: C11H22O2, MW: 186.29, [ ]20Dα  = -30.7 (c = 1.0, CHCl3); DC: Rf = 0.3 
(Et2O 2:1), UV (-), Vanillin: dark blue. 
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13C NMR (100 MHz, CDCl3): δ = 146.2 (s, C-5), 121.1 (d, C-6), 75.8 (d, C-3), 62.6 
(s, C-1), 44.4 (s, C-4), 32.7 (t, C-2), 22.8, 21.1 (q, C4-(CH3)2), 20.1 (t, C-1’), 14.3, 
13.6 (q, C-7, C-2’);  
 
MS (70 eV, EI): m/z (%): 186.0 (0.6) [M]+ , 177.0 (1), 141.0 (3), 112.0 (100), 96.9 
(19), 83.0 (75), 74.9 (13), 68.9 (60), 54.9 (34).  
 
HRMS (EI):  calcd  for C11H22O2  186.1620,  
                     found 186.157. 
 
 
 
(4S)-4-[(E)-2-Ethyl-1,1-dimethyl-2-butenyl]-2,2-dimethyl-1,3-dioxane (69): 
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Anhydrous CuSO4 (478 mg, 3.0 mmol, 1.5 equiv), pTsOH . H2O (76 mg, 0.4 mmol, 
0.2 equiv), and pyridine (24 mL, 0.3 mmol, 0.15 equiv) was added to a solution of 
diol 68 (372 mg, 2.0 mmol) in acetone (30 mL). The mixture was stirred for 24 h at 
room temperature. Saturated aqueous NaHCO3 solution (40 mL) was added and the 
aqueous layer was extracted with Et2O (4x60 mL). The combined organic extracts 
were dried over MgSO4 and carefully concentrated in vacuo. Purification of the 
residue by flash chromatography (pentane/Et2O 40:1) gave acetonide 69 (812 mg,  
90%) as a colorless oil. 
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General Data:  C14H26O2, MW: 226.36; [ ]20Dα = +14.3 (c = 1.0, CHCl3); DC: Rf = 0.84 
(Et2O), UV (-), Vanillin: black 
 
1H NMR (400 MHz,  CDCl3):  δ = 5.32  (q,  3J  = 6.8 Hz,  1H,  H-3'),  3.88  (dt,  2J = 
11.8 Hz,  3J = 2.9 Hz,  1H, H-6),  3.80  (ddd,  2J = 11.6 Hz,  3J = 5.5 Hz,  3J = 2.0 Hz, 
1H, H-6), 3.70 (dd, 3J = 11.6 Hz, 3J = 2.5 Hz, 1H, H-4), 2.18 - 2.00 (m, 2H,  
CH3CH2C=C), 1.62 (d, 3J = 6.8 Hz, 3H, H-4'), 1.59 - 1.46 (m, 1 H ;  
H-5), 1.41, 1.35 (2 s, 23H, C2-CH3), 1.18 (ddd, 2J = 13.1 Hz, 3J = 4.7 Hz, 3J = 2.6 Hz, 
1 H ; H-5), 1.03, 1.00 (2 s, 23H, C1'-CH3), 0.98 (t, 3J = 7.5 Hz, 3H ; CH3CH2C=C) ;   
 
13C NMR (100 MHz, CDCl3): δ = 146.1 (d, C-3’), 119.2 (d, C-4’), 98.3 (s, C-2), 74.2 
(d, C-4), 60.4 (t, C-6), 42.9 (s, C-1’), 29.9 (q, C2-CH3), 26.1 (t, C-5), 24.2, 21.2, 19.1, 
(q, C2-CH3, C1’-CH3)  14.4, 13.6 (q, C-4’, C-2’). 
 
 
2-[ (4S)-2,2-dimethyl-1,3-dioxan-4-yl]-2-methyl-3-pentanone (58): 
 
 
3
45'
6'
1' 3'
4'
O OO
5
1
2
 
58 
 
A stream of ozone in oxygen was bubbled through a solution of acetonide 69 (226 
mg, 1.0 mmol) in CH2Cl2 (40 mL) at -78◦C until the blue color of the solution 
persisted. PPh3 (262 mg, 1.2 equiv) was added at -78◦C, the mixture was allowed to 
warm to room temperature within  4 h and concentrated in vacuo. Purification of the 
residue by flash chromatography (pentane/Et2O 5:1) furnished ethyl ketone 58 (182  
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mg, 85 %) as colorless crystals, m.p. 378 ◦C, identical, IR, 1H NMR, 13C NMR) with 
substance obtained from the previously described prenyl borane protocol.[64, 40d] 
 
 
(S)-3,5-Di-(tert-butyldimethylsilyloxy)-2-pentanone (71): 
 
 
3
4
5
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A solution of hemiacetal 77/78 (146 mg, 0.424 mmol); prepared by previous armin 
bauer methode[58]; in CH2Cl2 (70 mL) was cooled to -78 ◦C. A stream of ozone in 
oxygen was bubbled through the solution until the blue color persisted, then the 
excess of ozone was removed by bubbling N2 through the solution. PPh3 (333 mg, 
1.27 mmol, 3.0 equiv) was added, and the mixture was allowed to warm to room 
temperature. Stirring was continued until TLC indicated conversion of the 
intermediate product. The solvent was removed under reduced pressure, and the 
residue was purified by flash chromatography (pentane/Et2O 19:1) to yield methyl  
ketone 71 (101 mg, 69 %) as a colorless oil. 
 
General Data:  C17H38O3Si2, MW: 346.24; [ ]20Dα = -11.8 (c = 1.0, CHCl3); DC: Rf = 
0.24 (CH2Cl2/Et2O), UV (-), Vanillin: first red then change into black. 
 
1H NMR (400 MHz, CDCl3): δ = 4.15  (dd, 3J = 6.8 Hz,  3J = 5.3 Hz,  1H,  
H-3), 3.75 - 3.58 (m, 2H, H-1), 2.16 (s, 3H, H-5), 1.88 - 1.70 (m, 2H,  H-2), 0.92, 
0.88 (2 s,  2 x 9H,  OSiC(CH3)3),  0.06,  0.06,  0.04,  0.03  (4 s,  4 x 3H, 
OSi(CH3)2). 
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13C NMR (100 MHz, CDCl3): δ = 212.0 (s, C-4), 75.8 (d, C-3), 58.4 (t, C-1), 37.8 
(t, C-2), 25.9 , 25.7 (q, SitBu), 25.4 (q, C-5), 18.3 , 18.1 (s, SiC(CH3)3), - 5.0, - 5.1, 
- 5.4 (q, SiCH3).  
 
MS (PCI, NH3): m/z (%): 347 (100) [M+H]+ , 324 (17), 279 (93), 231 (4), 215 (7), 
157 (8), 94 (11) ;  
 
HRMS (EI): calcd for C17H38O3Si2  346.2360,  
                     found 346.235. 
 
 
5.2.0. Synthesis of Thiazole Fragment 41 
 
(3S,4E)-1,3-Di-(tert-butyldimethylsilyloxy)-4-methyl-5-(2-methyl-1,3-thia- 
zol-4-yl)-4-pentene (82): 
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nBuLi (23.5 mL, 58.7 mmol, 1.2 equiv of a 2.5 m solution  in  hexanes)  was  added  
dropwise  to  a  stirred  solution  of phosphonate 70 (14.64 g, 58.7 mmol, 1.2 equiv) 
in THF (150 mL) cooled to -78◦C. After the mixture was stirred at -78 ◦C for 1 h, a 
solution of methyl ketone 71 (16.96 g, 48.9 mmol, 1.0 equiv) in THF (100 mL) was 
added dropwise at -78 ◦C. The mixture was allowed to warm to room temperature 
within 12 h. The reaction was quenched with saturated aqueous NH4Cl solution (100  
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mL). The organic layer was separated and the aqueous layer was extracted with Et2O 
(3x100 mL). The combined organic extracts were dried over MgSO4 and concentrated  
 
in vacuo. Flash chromatography (CH2Cl2, then Et2O) yielded unconverted methyl 
ketone 71 (3.22 g, 22 %) and E olefin 82 (17.07 g, 79 %) as colorless oils.  
 
General Data: C22H43NOSSi2, MW: 441.82; [ ]20Dα  = -0.7 (c = 1.0, CHCl3); DC: Rf = 
0.18 (CH2Cl2/Et2O 3:2), UV (+), Vanillin: dark green  
 
1H NMR (400 MHz, CDCl3): δ = 6.91 (s, 1H, H-7), 6.47 (s, 1H,  
H-5), 4.31 (dd, 3J = 8.0 Hz, 3J = 4.6 Hz, 1 H ; H-3), 3.71 - 3.58 (m, 2 H, H-1) 2.70 (s, 
3 H ; H-9), 1.99 (d, 4J = 1.1 Hz, 3 H, H-10), 1.83 - 1.75 (m, 2 H, H-2), 0.89, 0.88 (2 s, 
2x 9 H ,  OSiC(CH3)3), 0.06, 0.00 (2s, 2x3H, OSi(CH3)2), 0.03 (s, 6H,  OSi(CH3)2)   
 
13C NMR (100 MHz, CDCl3): δ = 164.3 (s, C-8), 153.2 (s, C-6), 142.6 (s, C-4), 118.6 
(d, C-5), 115.0 (d, C-7), 75.0 (d, C-3), 59.6 (t, C-1), 39.8 (t, C-2), 25.9, 25.8 (q, 
SitBu), 19.2, 18.2 (s, SiC(CH3)3), 13.8, - 4.6, - 5.1, - 5.3, - 5.4 (q, SiCH3).  
 
MS (70 eV, EI): m/z (%): 441.2 (35) [M]+ , 384.1 (89) [M - tBu]+ , 356.1 (80), 309.1 
(49), 282.1 (65) [C14H24NOSSi]+ , 252.0 (70),178.0 (38), 147.0 (71), 73.1 (100) ;  
 
HRMS (EI): calcd for C22H43NO2SSi2 441.2553,  
                     found 441.255 
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(3S,4E)-3-(tert-Butyldimethylsilyloxy)-4-methyl-5-(2-methyl--thiazol-4-yl)-4-penten-
1-ol (83): 
N
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In a PE bottle, silyl ether 82 (13.255 g, 30.0 mmol) was dissolved in a mixture of 
Et2O (120 mL) and  MeCN  (120 mL). Aqueous 40 % hydrofluoric acid (20 mL) and 
finely ground splinters of glass (133 mg) were added at 0 8C to the vigorously stirred 
mixture. The mixture was stirred for 2 h at 0◦C. Hydrofluoric acid (20 mL) was added 
and stirring was continued for 1 h at 0◦C. The reaction was quenched by  
carefully adding solid NaHCO3 (84.0 g, 1.0 mol) within 15 min at 0◦C. After  
the mixture was stirred for 30 min at 0◦C, water was added until the solids  
dissolved (the pH was adjusted to 6-8 by further addition of NaHCO3, if  
necessary).  The mixture was extracted with CH2Cl2 (4 x200 mL). The combined 
organic extracts were washed with brine (100mL), dried over  
MgSO4, and concentrated in vacuo. Purification of the residue by flash  
chromatography (pentane/Et2O 4:1) afforded alcohol 83 (9.041 g, 92 %) as viscous 
colorless oil. 
 
General Data: C16H29NOSSi2, MW: 327.56; [ ]20Dα  = -32.0 (c = 1.0, CHCl3); DC: Rf = 
0.52 (Et2O), UV (+), Vanillin: dark green.  
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1H NMR (400 MHz, CDCl3): δ (ppm):  6.92 (s, 1H, H-7), 6.52 (s, 1H, H-5), 4.38 (dd, 
3J = 7.4 Hz, 3J = 4.5 Hz, 1 H, H-3), 3.80-3.67 (m, 2H, H-1), 2.70 (s, 3 H, H-9), 2.40 
(s, 1H, OH), 2.01 (d, 4J = 1.2 Hz, 3 H, H-10), 1.93-1.76 (m, 2 H, H-2), 0.91 (s, 9 H 
,OSiC(CH3)3),  0.10,  0.03  (2s,  2x3 H, OSi(CH3)2).  
 
13C NMR (100 MHz, CDCl3): δ= 164.5 (s, C-8), 152 (s, C-6), 141.53 (s, C-4), 118.77 
(d, C-5), 115.35 (d, C-7), 77.42 (d, C-3), 60.35 (t, C-1), 38.12 (t, C-12), 25.77 (q, 
SitBu), 19.16 (q, C-9), 18.08 (s, SiC(CH3)3), 14.33 (q, C-10), -4.66, -5.26 (q, SiCH3). 
 
MS (70 eV, EI): m/z (%): 327 (18) [M]+, 282 (39), 270 (94), [M + tBu]+, 268 (29), 
252 (12), 240 (14), 178 (41), 168 (100), 164 (23), 105  
(27), 75 (59), 73 (42) ;  
 
HRMS (EI): calcd for C16H29NO2SSi 327.1688,  
                     found 327.168. 
 
(3S,4E)-3-(tert-Butyldimethylsilyloxy)-4-methyl-5-(2-methyl-1,3-thiazol-4- 
yl)-4-pentenal (84) 
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Dess-Martin periodinane (478 mg, 2.91 mmol, 1.3 equiv) was added to a solution of 
alcohol 83 (732 mg, 2.24 mmol) in CH2Cl2 (10 mL). The mixture was stirred for 30 
min at room temperature. The solvent was removed under reduced pressure. Flash  
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chromatography (pentane/Et2O 4:1) yielded aldehyde 84 (614 mg, 84 %) as a pale 
yellow oil.  
 
General Data: C16H27NO2SSi2, MW: 325.54; [ ]20Dα  = -19.2 (c = 1.0, CHCl3); DC: Rf = 
0.68 (Et2O), UV (+), Vanillin: dark green 
 
1H NMR (400 MHz, CDCl3): δ (ppm) =  9.79 ( t, 3J = 2.7 Hz, 1 H, H-1), 6.94 (s, 1 H, 
H-7), 6.56 (s, 1 H, H-5), 4.69 (dd, 3J = 8.2 Hz, 3J =4.0 Hz, 1 H ; H-3), 2.75 (ddd, 2J = 
15.5 Hz, 3J = 7.7 Hz, 3J = 2.9 Hz, 1 H, H-2), 2.70 (s, 3 H, H-9), 2.51 (ddd, 2J =15.5 
Hz, 3J = 4.0 Hz, 3J = 2.1 Hz, 1 H ; H-2), 2.04 (d, 4J = 1.2 Hz, 3 H, H-10), 0.88 (s, 9 H, 
OSiC(CH3)3), 0.08,0.03 (2 s, 2 x3H, OSi(CH3)2).  
 
13C NMR (100 MHz, CDCl3): δ (ppm) = 201.5 (d, C-1), 164.8 (s, C-8), 152.6 (s, C-
6), 140.5 (s, C-4), 119.3 (d, C-5), 115.9 (d, C-7), 73.9 (d, C-3), 50.1 (t, C-2), 25.7 (q, 
SitBu), 19.2 (q, C-9), 18.1 (s, SiC(CH3)3), 14.1, - 4.6, - 5.2 (q, SiCH3);  
 
MS (70 eV, EI): m/z (%): 325 (6) [M]+ , 282 (24), 268 (98) [M - tBu]+ , 250 (17),  
194  (13),  176  (100),  164  (19),  135  (15),  101  (20),  75  (32),  73  (31) ;  
 
HRMS (EI): calcd for C16H27NO2SSi 325.1532,  
                     found 325.153 
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(4S,6E)-4-(3-(tert-butyldimethylsilyloxy)-2-methylhexa-1,5-dienyl)-2-methylthiazole 
(84a): 
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A  mixture  of  methyl  triphenyl  phosphoniumbromide  (1.197 g,  3.35 mmol,  1.85 
equiv),  NaNH2   (131 mg,  3.35 mmol, 1.85 equiv), and THF (10 mL) was stirred for 
30 min at room temperature. A solution of aldehyde 84 (589 mg, 1.81 mmol) in THF 
(5 mL) was added dropwise over 10 min.  The mixture was stirred for 15 min at room 
temperature, poured into saturated aqueous NaHCO3 solution (60mL),  
and extracted with Et2O. The combined organic layers were washed with  
brine and dried over MgSO4. After removal of the solvents under reduced  
pressure, flash chromatography (pentane/Et2O 19:1) of the residue afforded olefin  
 
84a (498 mg, 85 %) as a pale yellow oil, identical (IR, 1H NMR, 13C NMR) with 
substance obtained from the previously described by armin bauer protocol.[58].  
 
 
 
 
 
 
 
 
Experimental Part                                                                                                       71 
 
(1E,3S)-3-(tert-Butyldimethylsilyloxy)-2-methyl-1-(2-methyl-1,3-thiazol-4-yl)-1,5-
hexadiene (41): 
 
N
S
OH
1
2
3
4
5
6
7
8
9
10
 
41 
 
TBAF (4.0 mL, 1.0 M in THF, 4 mmol, 3 equiv) was added at 0◦C to freshly activate 
molecular sieves 4◦A in THF (16 mL). The mixture was stirred for 45 min at room 
temperature. A solution of silyl ether 84a (444 mg, 1.37 mmol) in THF (2 mL) was 
added, and stirring was continued for 80 min at 0◦C. The mixture was poured into 
saturated aqueous NH4Cl solution (35 mL) and extracted with Et2O (4X). The 
combined organic layers were washed with brine and dried over MgSO4. Evaporation 
of the solvent under reduced pressure, followed by flash filtration with Et2O over a 
short silica gel column afforded alcohol 41 (283 mg, 99 %) as a colorless oil. 
 
General Data: C11H15NOS, MW: 209.31; [ ]20Dα  = -18.5 (c = 1.0, CHCl3); DC: Rf = 
0.42 (Et2O), UV (+), Vanillin: dark blue. 
 
 
1H NMR (400 MHz, CDCl3): δ(ppm) = 6.92 (s, 1 H, H-8), 6.46 (s, 1 H,  
H-6), 5.83-5.72 (m, 1 H, H-2), 5.08-4.97 (m, 2 H, H-1), 4.15 (t, 3J = 6.4 Hz,  
1 H, H-4), 2.70 (s, 3 H, H10-CH3), 2.40 - 2.25 (m, 2 H, H-3), 2.00 (d, 4J =  
1.0 Hz, 3 H, H-11). 
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13C NMR (100 MHz, CDCl3): δ(ppm) = 164.4 (s,C-9),  153.1 (s, C-7), 142.0 (s, C-5), 
135.3 (d, C-2), 118.8 (d, C-6), 116.5 (t, C-1), 115.1 (d, C-8), 78.5 (d, C-4), 41.4 (t, C-
3), 25.8 (q, C-13), 19.2 (q. C-10) , 13.9 (q, C-11). 
 
MS (PCI, NH3): m/z (%): 324 (100) [M+H]+ , 308 (1) [M - CH3]+ , 282 (7), 266 (1)  
[M-tBu]+ , 192 (4), 94 (3) ;  
 
HRMS (EI): calcd for C17H29NOSSi 323.1739,  
                     found 323.173.  
 
5.2.1. Total Synthesis of 8,9-dehydro Epothilone C 
 
Methyl trans-Hepta-2,6-dienoate (86): 
 
O
MeO 1
2
3
4
5
6
7
 
86 
 
Based on Crandal procedure [63], sodium metal (1.09, 47.6 mmol) was dissolved in 60 
ml of anhydrous methanol while cooling in ice bath to 0◦C. A vigorous reaction 
ensued and the temperature rose to 40◦C. When reaction mixture returned to 0◦C, 
methyl diethylphosphonoacetate (10.0 g, 47.64 mmol) was added. The reaction 
mixture was stirred for 15 minutes at room temperature, and was again cooled to 0◦C. 
4-Pentenal 85 (3.36 ml, 34.0 mmol) was added via syringe. The mixture was stirred at 
room temperature for 1.5 h, after which 60 ml of water was added and the mixture 
was extracted with ether (3x60 ml). The organic phase was washed with brine (60 
ml), dried over MgSO4, filtered and concentrated giving 3.35 g (70% yield) of the 
title compound as light yellow oil. 
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General Data: C8H12O2, MW: 140.18; DC: Rf = 0.7 (Pentene/Et2O 1:1), UV (+), 
Cerium: blue.  
IR (film) 
~
V (cm-1): 2860 (m), 2750 (s), 1720 (s), 1680 (s), 1650 (s),  
 
1H NMR (400 MHz, CDCl3): δ(ppm) = 6.98 (dt, 3J = 16.0 Hz, 3J = 6.5, 1H, H-3), 
5.84 (d, 3J = 16.0 Hz, 1H, H-2), 5.79 (ddt, 3J = 16.5 Hz, 10.0 Hz, 6.5 Hz, 1H, H-6), 
5.05 (dd, 3J = 16.5 Hz, 2.0Hz, 1H, H-7), 5.00 (dd, 3J = 10.0 Hz, 2.0 Hz, 1H, H-7), 
3.72 ( s, 3H, CH3), 2.31-2.29 (m, 2H, H-4), 2.24-2.21 (m, 3H, H-5). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm)  = 167. 1 ( s, C-1), 148.7 ( C-3, d), 137.1 (C-6, 
d), 121.4 (C-2, d), 115.7 ( C-7, t), 51.5 ( CH3, q), 32.1 ( C-4, t), 31.6 ( C-5, t) 
 
 
(E)-hepta-2,6-dien-1-ol (87) [63] :  
 
1
2
3
4
5
6
7
OH
 
                                                               87 
 
A solution of Methyl trans-Hepta-2,6-dienoate 86 (1.5 g, 10.8 mmol) in 36 ml 
anhydrous THF was cooled to -78◦C and DIBAL-H (1.0 M solution in Hexan 
fraction, 28.06 ml, 28.06 mmol) was added slowly. The mixture was stirred for 2 hr at 
-78◦C. The mixture was chilled in ice bath and then quenched by sequential addition 
of 1.2 ml 15% NAOH, 3.0 ml H2O, and 1.2 ml Et2O. The mixture was stirred at room 
temperature for 30 minutes and the dried over MgSO4 and filtered. After removal of 
the solvents under reduced pressure, flash chromatography (pentane/Et2O 15:1) of the 
residue afforded alcohol 87 (0.96 g, 80 %) as a pale yellow oil and the spectral data 
were consistent to the previous report [63]. 
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General Data: C7H12O, MW: 112.17; DC: Rf = 0.21 (Pentene/Et2O 3:1), UV (-), 
vanillin: black 
 
1H NMR (400 MHz, CDCl3): δ (ppm) = 5.71-5.85 (m, 1H, H-6), 5.21-4.75 (m, 2H, 
H-2, H-3), 5.00-5.06(m, 1H, H-7), 4.81-4.90 (m, 1H, H-7), 4.08(d, 3J = 4.8 Hz, 2H, 
H-1), 2.10-2.15 (m, 4H, H-4, H-5),1.42 (br s, OH)  
 
13C-NMR (100 MHz, CDCl3): δ(ppm) = 138.90 (d, C-6), 129.8 (d, C-2), 128.0 (d, C-
3), 116.4 (t, C-7), 65.4 (t, C-1), 35.9 (t, C-5), 34.4 (t, C-4) 
 
HRMS (EI): calcd for C7H12O 112.1701,  
                     found 112.1702.  
 
(E)- 2,6-Heptadienal (88): 
O
H 1
2
3
4
5
6
7
 
88 
 
To a solution of 87 (1.0315 gr, 9.2894 mmol) in dry CH2Cl2 (15 ml) was added Dess-
Martin periodinane reagent (4.334 g, 10.2183 mmol) at 0◦C in several portion, and the 
reaction mixture was stirred at room temperature for 1 hr. The mixture was diluted 
with Et2O and the former precipitate was filtered off and the filtrate was concentrated 
under reduced pressure without heat and the residue was purified by flash 
chromatography (pentene/Et2O 10:1) to give 88 (0.8915 g, 86%) as colorless liquid. 
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General Data: C7H10O, MW: 110.15; DC: Rf = 0.36 (Pentene/Et2O 4:1), UV (+), 
vanillin: black. 
IR (film) 
~
V  (cm-1): 1700 (C=O) cm-1 
 
1H NMR (400 MHz, CDCl3): δ (ppm) = 9.40 (d, 3J = 8Hz,1H, H-1), 6.80-6.91 (m, 
1H, , H-3), 6.10-6.21 (m, 1H, H-2), 5.70-5.19 (m, 1H, H-6), 5.11-5.02 (m, 2H, H-7), 
2.10-2.50 (m, 4H, H-4, H-5). 
 
 
13C-NMR (100 MHz, CDCl3): δ(ppm) = 193.90 (d, C-1), 157.59 (d, C-3), 134.3 (d, 
C-6), 133.1 (d, C-2), 115.94 (t, C-7), 31.82 (t, C-5), 31.77 (t, C-4). 
 
MS (70 eV, EI): m/z (%): 110 (4, [M]+), 109 (14), 95 (32), 81 (100), 79 (42), 41 (71). 
 
HRMS (EI): calcd for C7H10O 110.1701,  
                     found 110.1702. 
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(E)-(4R,5S,4’S)-2-(-2,2-dimethyl-1,3-dioxan-4-yl)-5-hydroxy-2,4-dimethylundeca-
6,10-dien-3-one (89): 
        
1
2 3 4 5
6
7
8
9
10
11
2´
3´
O O OHO
1`
 
89  
 
 
 
A solution of ethyl ketone 58 (1.55 g, 7.26 mmol) in THF (2.0 mL) was added to a 
freshly prepared solution of LDA [n-BuLi (4.3 mL, 1.6 m solution in hexanes, 6.97 
mmol, 0.96 equiv) was added to a solution of diisopropylamine (0.977 mL, 6.97 
mmol) in THF (11.0 mL) at 0◦C] dropwise at - 78◦C.  The solution was stirred for 1 h 
at - 78◦C. Aldehyde 88 (800 mg, 7.2628 mmol, 1.0 equiv) was added dropwise and 
stirring was continued for 45 min at at -78◦C. The reaction mixture was quenched by 
dropwise addition of saturated aqueous NH4Cl solution at -78◦C. The  
organic layer was separated and the aqueous layer was extracted with Et2O.  
The combined extracts were dried over MgSO4 and concentrated in vacuo.  
Flash chromatography (pentane/Et2O 10:1) of the residue afforded major 
diastereoisomer 89 (0.92 g, 60%) as colorless oils.  
 
General Data: C19H32O4, MW: 324.45; DC: Rf = 0.2 (Pentene/Et2O 3:1), UV (-), 
vanillin: black. 
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IR (film) 
~
V (cm-1): 3409 (w), 2956 (s), 2938 (s), 2876 (m), 1694 (s), 1467 (m), 
1381(s), 1372 (w), 1255 (s), 1094 (m), 971(m), 882 (w) cm 
 
 
1H NMR (400 MHz, CDCl3): δ (ppm): 5.77-5.84 (m, 1H, H-10), 5.67-5.76 (dt, 1H, 
3J=8 Hz, 3J= 2.0 Hz, H-7), 5.37-5.43 (dd, 1H, 3J = 21.3, 3J = 5.2, H-6), 4.92-5.31 (m, 
2H, H-11), 4.23-4.28 (m, 1H, H-5), 4.02-4.07 ( dd, 3J= 11.9 Hz, 3J= 2.5, 1H, H-4`), 
3.94 (dt, 2J= 11.8 Hz, 2J= 2.7 Hz, 1H, H-6`), 3.85 ( ddd,  3J= 11.2 Hz, 3J= 4.1 Hz, 3J= 
1.5 Hz, H-6`), 3.39 (s, 1H, OH), 3.02-3.10 (dq, 3J= 7.1 Hz, 3J= 2.6 Hz, 1H, H-4), 
2.11-2.14 (m, 4H, H-8, H-9), 1.6-1.69 (m, 2H, H-5`), 1.4 (s, 3H, C2`-CH3), 1.31 (s, 
3H, H-1), 1.2 (s, 3H,  C2`-CH3), 1.1 (s, 3H, C2-CH3), 1.03-1.07 ( d, 3J= 7.0 Hz, 3H, 
C4-CH3). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 138,115 (d, C-10), 131.590 (d, C-6), 129. 763 
( d, C-7), 114.77 ( t, C-11), 98.468 (s, C-2`), 74.73  (d, C-4`), 71.9 (d-C-5), 59.73 (t, 
C-6`), 51.34 ( s, C-2), 45.5 (d, C-4), 33.31 (t, C-9), 31.7 (t, C-8), 29.71 (q, C2`-CH3), 
25.03 (t, C-5`), 21.24 (q, C-1), 19.00 (q, C2-CH3), 18.05 (q, C2-CH3), 10.094 (q, C4-
CH3). 
 
MS (70 eV, EI): m/z (%): 324 (1<, [M]+), 306 (26, [M+-H2O], 266  (3),  248  (20),  
198  (8),  169  (20),  167  (14) , 143 (86), 131 (72), 117 (38), 99 (82), 93 (63), 83 (28). 
 
HRMS (EI): calcd for C19H32O4  324.230,  
                     found 324.241. 
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(E)-(4R,5S,4’S)-5-(tert-butyldimethylsilyloxy)-2—(2,2-dimethyl-4,6-dioxan-4-yl)-
2,4-dimethylundeca-6,10-dien-3-one (85): 
 
            
1
2 3 4 5
6
7
8
9
10
11
2´
3´
O O OTBSO
1`
 
90 
 
2,6-Lutidine  (0.515 ml, 3.7 mmol, 2.0 equiv)  and TBSOTf (0.7644 mL, 3.69 mmol, 
1.5 equiv) were slowly added at - 78◦C to a solution of alcohol 84 (700 mg, 2.21 
mmol) in CH2Cl2  (20 ml). The mixture was stirred at -78◦ C for 30 min and at 0◦C for 
1 h. Saturated aqueous NaHCO3 solution was added and the mixture was extracted 
with CH2Cl2. The combined extracts were dried over MgSO4 and concentrated in 
vacuo. Silyl ether 85 (774 mg, 80%) was obtained as a colorless oil after  
purification of the residue by flash chromatography (pentane/Et2O 20:1). 
 
General Data: C25H46O4Si, MW: 438.72; DC: Rf = 0.62 (Pentene/Et2O 1:1), UV (-), 
vanillin: black. 
 
IR (film) 
~
V (cm-1):  2957 (s), 2931 (m), 2886 (w), 2858 (m), 1697(s), 1473(w) , 1256 
(m), 1103 (m), 987 (w), 836 (s) , 775 (s). 
 
1H NMR (400 MHz, CDCl3): δ (ppm): 5.79-5.87 (m, 1H, H-10), 5.70-5.76 (dq, 1H, 
3J=9 Hz, 3J= 2.0 Hz, H-7), 5.37-5.43 (dd, 1H, 3J = 21.3, 3J = 5.2, H-6), 5.02-5.31 (m, 
2H, H-11), 4.29-4.38 (ddd, 3J = 7.5, 3J =3.9, 3J= 3.6, 1H, H-5), 4.10-4.17 ( dd, 3J=  
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11.9 Hz, 3J= 2.5, 1H, H-4`), 3.94 (dt, 2J= 11.8 Hz, 2J= 2.7 Hz, 1H, H-6`), 3.85 ( ddd,  
3J= 11.2 Hz, 3J= 4.1 Hz, 3J= 1.5 Hz, H-6`), 3.12-3.20 (dq, 3J= 7.1 Hz, 3J= 2.6 Hz, 1H, 
H-4), 2.11-2.14 (m, 4H, H-8, H-9), 1.6-1.69 (m, 2H, H-5`), 1.4 (s, 3H, C2`-CH3), 1.31 
(s, 3H, H-1), 1.2 (s, 3H,  C2`-CH3), 1.1 (s, 3H, C2-CH3), 1.03-1.07 ( d, 3J= 7.0 Hz, 
3H, C4-CH3), 0.91 (s, 1x9H; OSiC(CH3)3), 0.09, 0.1 ( 2s, 2x3H; OSi(CH3)2). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 215,84 (s, C-3), 138,99 (d, C-10), 133.590 (d, 
C-6), 130. 763 ( d, C-7), 114.34 ( t, C-11), , 74.73  (d, C-4`), 71.9 (s,C-5), 59.73 (t, C-
6`), 51.34 ( s, C-2), 45.5 (d, C-4), 33.31 (t, C-9), 31.7 (t, C-8), 29.71 (q, C2`-CH3), 
27.08 (q, OSiC(CH3)3, 25.03 (t, C-5`), 23.24 (q, C-1), 21.00 (q, C2-CH3), 20.05 (q, 
C2-CH3), 18.5, 18.4 (s, OSiC(CH3)3), 15.094 (q, C4-CH3), -4.9 , -4.0  (q, OSi(CH3)2). 
 
MS (70 eV, EI): m/z (%): 324 (1<, [M]+), 306 (26, [M+-H2O], 266  (3),  248  (20),  
198  (8),  169  (20),  167  (14) , 143 (86), 131 (72), 117 (38), 99 (82), 93 (63), 83 (28). 
 
HRMS (EI): calcd for C21H23O4Si  [M+-t-Bu] 380.9601 
                     Found 380.9602 
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(E)-(4R,5S,3’S)-5-(tert-butyldimethylsilyloxy)-1,3-dihydroxy-2,2,4-trimethyltrideca-
6,10 -dien-3-one (91):  
1
2 3 4 5
6
7
8
9
10
11
2´
3´
OH O OTBSOH
 
                                                             
91 
 
A solution of acetonide protected diol 89 (0.1660 gr, 0.3784 mmol) in CH3CN (6.3 
ml) was added H2O (0.903 ml) followed by CeCl3.7H2O (0.423 g, 1.1352 mmol) at 
ambient temperature. The reaction was stirred at reflux temperature for 1.5 hr. After 
completion as indicated by TLC, the reaction mixture was diluted with Et2O, 
quenched with NaHCO3 (saturated aq), and the aqueous layer was re extracted with 
Et2O (2X). The organic layer was dried over MgSO4, filtered, and concentrated under 
reduced pressure. Flash chromatography (5:1, Pentene:Et2O) provided 0.1182 gr of 
diol 91 in 78% yield as clear oil. 
 
General Data: C22H42O4Si, MW: 398.65; DC: Rf = 0.62 (Pentene/Et2O 1:1), UV (-), 
vanillin: black. 
IR (film) 
~
V (cm-1):  3425 (br s), 2958 (m), 2886 (w), 2858 (m), 1680 (s), 1473(w) , 
1256 (m), 1103 (m), 987 (w), 836 (s) , 775 (s). 
 
1H NMR (400 MHz, CDCl3): δ (ppm): 5.83-5.87 (m, 1H, H-10), 5.79-5.66 (dq, 1H, 
3J=9 Hz, 3J= 2.0 Hz, H-7), 5.47-5.40 (dd, 1H, 3J = 21.3, 3J = 5.2, H-6), 5.02-5.31 (m, 
2H, H-11), 4.29-4.38 (m, 1H, H-5), 4.10-4.17 (m, 1H, H-3`), 3.82-3.86 (m, 2H, H-1’), 
3.39-3.40 (m, 1H, 3’-OH), 3.12-3.20 (dq, 3J= 7.1 Hz, 3J= 2.6 Hz, 1H, H-4), 2.69 (br s, 
1H, 1’-OH), 2.10-2.13 (m, 4H, H-8, H-9), 1.62-1.67 (m, 2H, H-2`), 1.41 (s, 3H, H-1),  
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1.2 (s, 3H, C2-CH3), 1.03-1.07 (d, 3J= 7.0 Hz, 3H, C4-CH3), 0.91 (s, 1x9H; 
OSiC(CH3)3), 0.09, 0.1 ( 2s, 2x3H; OSi(CH3)2). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 138,115 (d, C-10), 131.590 (d, C-6), 129. 763 
( d, C-7), 114.77 ( t, C-11), 76.73  (d, C-3`), 74.9 (s,C-5), 62.34 (t, C-1`), 52.34 ( s, C-
2), 45.5 (d, C-4), 33.31 (t, C-9), 32.50 (t, C-2’), 26.7 (t, C-8), 25.15(q, OSiC(CH3)3, 
23.24 (q, C-1), 21.00 (q, C2-CH3), 20.05 (q, C2-CH3), 18.5, 18.4 (s, OSiC(CH3)3), 
15.094 (q, C4-CH3), -4.9 , -4.0  (q, OSi(CH3)2). 
 
MS (70 eV, EI): m/z (%): 397.1 (1<, [M]+), 339.43 [M+- tBu],  282.20 (5), 265.43  
(100) [M+- OTBS],  248  (20),  167  (14) , 155.43 (22), 143 (86), 105.43 (77), 75(79). 
 
HRMS (EI): calcd for C22H42O4Si: 398.290 
                     Found: 398.302 
  
 
(E)-(4R,5S,3’S)-(1,3,5-Tris-(tert-butyldimethylsilyloxy)-2,2,4-trimethyltrideca-6,10-
dien-3-one (92): 
 
1
2 3 4 5
6
7
8
9
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2´
3´
OTBS O OTBSOTBS
 
 
92 
 
2,6-Lutidine  (0.336 ml, 2.8 mmol, 8.0 equiv)  and TBSOTf (0.344 ml, 1.49 mmol, 
4.1 equiv) were slowly added at - 78◦C to a solution of alcohol 91 (380 mg, 0.36 
mmol) in CH2Cl2  (2 ml). The mixture was stirred at -78◦ C for 30 min and at 0◦C for 
1 h. Saturated aqueous NaHCO3 solution was added and the mixture was extracted 
with CH2Cl2. The combined extracts were dried over MgSO4 and concentrated in  
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vacuo. Silyl ether 92 (0.2142 g, 90%) was obtained as a colorless oil after  
purification of the residue by flash chromatography (pentane/Et2O 20:1). 
 
General Data: C34H70O4Si3, MW: 627.17; DC: Rf = 0.62 (Pentene/Et2O 1:1), UV (-), 
vanillin: black.  
 
IR (film) 
~
V (cm-1):  2957 (s), 2931 (m), 2886 (w), 2858 (m), 1679 (s), 1473(w), 1257 
(s), 1099 (br s), 987 (w), 836 (s), 775 (s). 
 
1H NMR (400 MHz, CDCl3): δ (ppm): 5.83-5.87 (m, 1H, H-10), 5.70-5.66 (dt, 1H, 
3J=9 Hz, 3J= 2.0 Hz, H-7), 5.47-5.40 (dd, 1H, 3J = 21.3, 3J = 5.2, H-6), 5.02-5.31 (m, 
2H, H-11), 4.29-4.38 (m, 1H, H-5), 4.10-4.17 (m, 1H, H-3`), 3.80-3.85 (m, 2H, H-1’), 
3.10-3.219 (dt, 3J= 7.1 Hz, 3J= 2.6 Hz, 1H, H-4), 2.69 (br s, 1H, 1’-OH), 2.10-2.13 
(m, 4H, H-8, H-9), 1.62-1.67 (m, 2H, H-2`), 1.41 (s, 3H, H-1), 1.2 (s, 3H, C2-CH3), 
1.03-1.07 ( d, 3J= 7.0 Hz, 3H, C4-CH3), 0.89 (s, 2x 9H, C3’-SiC(CH3)3, C5-
SiC(CH3)3), 0.87, (s, 9H, C1’-SiC(CH3)3 ), 0.08, 0.05 (s, 2x3H, C5-OSiC(CH3)2), 0.05 
(s, 2x3H, C3’-OSiC(CH3)2), 002,0.01 (s, 2x3H, C1’-OSiC(CH3)2). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 218.25 (s, C-3), 138.115 (d, C-10), 131.590 
(d, C-6), 129. 763 ( d, C-7), 114.77 ( t, C-11), 76.73  (d, C-3`), 74.9 (s,C-5), 61.34 (t, 
C-1`), 52.34 ( s, C-2), 45.5 (d, C-4), 33.31 (t, C-9), 32.50 (t, C-2’), 26.7 (t, C-8), 
26.22 (q, C5-OSiC(CH3)3), 26.11 (q, C3`-OSiC(CH3)3), 25.96 (q, C1’-OSiC(CH3)3), 
24.52 (q, C2-CH3), 20.05 (q, C2-CH3), 18.52 (s, C5-OSiC(CH3)3), 18.34 (s, C3’-
OSiC(CH3)3, 18.29 (s, C1-OSiC(CH3)3), 15.094 (q, C4-CH3), -5.24, -5.27 (q, C1’-
OSi(CH3)2), -3.78, -3.97 (q, C3’-OSi(CH3)2), -3.66, -3.69 (q, C5-OSi(CH3)2). 
 
MS (70 eV, EI): m/z (%): 624 (1<, [M]+), 566.03 [M+- tBu],  546.40 (2) [C1`- C5+],   
434.27 (5), 394.27 (20),  304. 23 (100) [C1`- C3’+], 226.18 (71) [C5- C11+], 166 (17), 
140 (21), 104 (58), 84.27 (44), 68 (44). 
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HRMS (EI): calcd for C34H70O4Si3: 624.460  
                     Found: 624.468. 
 
(E)-(4R,5S,3’S)-(3,7-Bis-(tert-butyldimethylsilyloxy)-1-hydroxy-2,2,4 
trimethyltrideca-6,10-dien-3-one (93): 
1
2 3 4 5
6
7
8
9
10
11
2´
3´
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93 
 
To a solution of 92 (0.3486 g, 0.556 mmol) in THF (12 ml) was added a stock 
solution of HF.Py (this stock was prepared by addition of 1.0 ml HF.Py to 2.5 ml 
pyridine in 5 ml THF) at 0◦C. The resulting reaction mixture was warmed to 25◦C by 
removing the ice-bath and allowed to stir at that temperature until starting material 
was gone. Saturated NaHCO3 solution was added to quench the reaction and two 
layers were separated. The aqueous layer was extracted with ethyl acetate (50ml x 3). 
The combined organic extracts were dried over MgSO4, and the solvents were 
removed under reduced pressure. The crude product obtained was subjected to 
column chromatography over silica gel with 10:1 pentene:ether as eluent to yield the 
desired primary alcohol 93 (0.195 g, 70%) as pale yellow oil.   
 
General Data: C28H56O4Si2, MW: 512.91; DC: Rf = 0.62 (Pentene/Et2O 1:1), UV (-), 
vanillin: black.  
 
IR (film) 
~
V (cm-1):  3460.47 (s), 2930 (s), 2886 (w), 2858 (m), 1694 (s), 1464(w), 
1361.31 (s), 1094 (br s), 988 (w), 836 (s), 775 (s).  
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1H NMR (400 MHz, CDCl3): δ (ppm): 5.71-5.85 (m, 1H, H-10), 5.46-5.22 (dt, 1H, 
3J=9 Hz, 3J= 2.0 Hz, H-7), 5.30-5.35 (dd, 1H, 3J = 15.0, 3J = 7.2, H-6), 4.92-5.08 (m, 
2H, H-11), 4.10-4.15 (t, 3J= 15.1, 1H, H-5), 4.00-4.05 (m, 1H, H-3`), 3.60-3.68 (m, 
2H, H-1’), 3.0-3.09 (dt, 3J= 7.1 Hz, 3J= 2.6 Hz, 1H, H-4), 2.01-2.11 (m, 4H, H-8, H-
9), 1.83 (s, 1H, OH), 1.59-1.62 (m, 2H, H-2`), 1.19 (s, 3H, H-1), 1.05-1.12 (d, 3J= 7.0 
Hz, 3H, C4-CH3) ,0.98 (s, 3H, C2-CH3), 0.89 (s, 2x 9H, C3’-SiC(CH3)3, C5-
SiC(CH3)3), 0.87, (s, 9H, C1’-SiC(CH3)3 ), 0.08, 0.05 (s, 2x3H, C5-OSiC(CH3)2), 0.05 
(s, 2x3H, C3’-OSiC(CH3)2), 002,0.01 (s, 2x3H, C1’-OSiC(CH3)2). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 218.73 (s, C-3), 138.28 (d, C-10), 132.19 (d, 
C-6), 129. 763 ( d, C-7), 114.67 ( t, C-11), 75.87  (d, C-3`), 72.9 (s,C-5), 60.34 (t, C-
1`), 53 ( s, C-2), 38.428 (d, C-4), 33.1 (t, C-9), 32.25 (t, C-2’), 31.5 (t, C-8), 28.98 (q, 
C5-OSiC(CH3)3), 28.88 (q, C3`-OSiC(CH3)3), 24.52 (q, C2-CH3), 21.05 (q, C2-CH3), 
18.52 (s, C5-OSiC(CH3)3), 18.34 (s, C3’-OSiC(CH3)3, 15.094 (q, C4-CH3), -3.78, -
3.97 (q, C3’-OSi(CH3)2), -3.66, -3.69 (q, C5-OSi(CH3)2). 
 
MS (70 eV, EI): m/z (%): 512.2 (1<, [M]+), 494.3[M+- H2O],  341.1 (100), 333.1 
(60), 225.1 [C7- C14+], 189 (24), 173 (8), 148 (8), 131 (13).     
 
HRMS (EI): calcd for C28H56O4Si2: 512.370 
                     Found:  512.3714 
 
 
 
 
 
 
 
 
Experimental Part                                                                                                       85 
 
(E)-(3’S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2,2,4-trimethyl-3-oxotrideca-6,10-
dienoic acid (94): 
1
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A  solution  of  PDC (1.07 g, 2.60 mmol,11.0 equiv)  in  DMF (3 ml)  was  added  to  
a  solution  of  alcohol 93 (123 mg, 0.273 mmol) in DMF (2 ml). The reaction 
mixture was stirred for 36 h at room temperature, mixed with brine (50 mL), diluted 
with water, and extracted with CH2Cl2. The combined extracts were dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash chromatography 
(pentane/Et2O 2:1) to furnish acid 94 (85.3 mg, 69 %) as a viscous, colorless oil. 
 
General Data: C28H54O5Si2, MW: 526.9; DC: Rf = 0.62 (Pentene/Et2O 2:1), UV (-), 
vanillin: black. 
 
IR (film) 
~
V (cm-1):  3084 (w), 2930 (s), 2858 (w), 1694 (s), 1472 (m), 1440(s), 1409 
(w), 1361.31 (s), 1094 (br s), 938 (w), 836 (s), 775 (s). 
 
1H NMR (400 MHz, CDCl3): δ (ppm): 5.71-5.82 (m, 1H, H-10), 5.46-5.22 (dt, 1H, 
3J=9 Hz, 3J= 2.0 Hz, H-7), 5.30-5.35 (dd, 1H, 3J = 15.0, 3J = 7.2, H-6), 4.92-5.08 (m, 
2H, H-11), 4.29-4.33(t, 3J= 15.1, 1H, H-5), 4.09-4.13 (m, 1H, H-3`), 3.01-3.09 (dt, 
3J= 7.1 Hz, 3J= 2.6 Hz, 1H, H-4), 2.46-2.53 (dd, 1H, 3J = 16.0, 2J = 2.2, H-2`), 2.29-
2.34 (dd, 1H, 3J = 16.0, 2J = 6.6, H-2`) 2.01-2.11 (m, 4H, H-8, H-9),  1.2 (s, 3H, H-1), 
1.19-1.22 (d, 3J= 7.0 Hz, 3H, C4-CH3) ,1.01 (s, 3H, C2-CH3), 0.89 (s, 2x 9H, C3’- 
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SiC(CH3)3, C5-SiC(CH3)3), 0.87, (s, 9H, C1’-SiC(CH3)3 ), 0.08, 0.05 (s, 2x3H, C5-
OSiC(CH3)2), 0.05 (s, 2x3H, C3’-OSiC(CH3)2), 002,0.01 (s, 2x3H, C1’-OSiC(CH3)2). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 138.01 (d, C-10), 132.12 (d, C-6), 131. 68 ( d, 
C-7), 114.82 ( t, C-11), 75.87  (d, C-3`), 73.9 (s,C-5), 53.41 (t, C-1`), 48.49 ( s, C-2), 
39.693 (d, C-4), 33.1 (t, C-9), 31.5 (t, C-2’), 31.1 (t, C-8), 29.68 (q, C5-OSiC(CH3)3), 
25.91 (q, C3`-OSiC(CH3)3), 23.52 (q, C2-CH3), 22.05 (q, C2-CH3), 18.52 (s, C5-
OSiC(CH3)3), 18.34 (s, C3’-OSiC(CH3)3, 15.094 (q, C4-CH3), -3.78, -3.97 (q, C3’-
OSi(CH3)2), -3.66, -3.69 (q, C5-OSi(CH3)2).  
 
MS (70 eV, EI): m/z (%): 527.1 (1<, [M+H]+), 491.2 (18),  469.2 [M-tBu], 333.1 
(60), 225.1 [C5- C14+], 189 (10), 173 (8), 73 (10). 
 
HRMS (EI): calcd C28H54O5Si2 for: 526.35 
                     Found:  527.3598 [M+H]+ 
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(3S,6R,)-((S,E)-2-methyl-1-(2-methylthiazol-4-yl)hexa-1,5-dien-3-yl)-3,7-bis(tert-
butyldimethylsilyloxy)-4,4,6-trimethyl-5-oxotrideca-8,12-dienoate (95): 
 
O
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A solution of EDCI (40 mg, 0.208 mmol) in 1 ml CH2Cl2 was added dropwise to 
solution of alcohol 41 (40.2 mg, 0.192 mmol), carboxylic acid 94 (84.3 mg, 0.160 
mmol) and DMAP (3.91 mg, 0.0302 mmol) in 1 ml CH2Cl2 at 0◦C for 15 minutes and 
4 hr at rt. The reaction mixture was poured to brine. The organic layer were separated, 
dried over MgSO4 and concentrated under vacuo. The resulting residue was separated 
by silica gel column (6:1 pentene/ether) to provide 88 mg (76%) of ester 95 as pale 
yellow oil.  
 
General Data: C39H67NO5SSi2, MW: 718.19; DC: Rf = 0.47 (Pentene/Et2O 4:1), UV 
(+), vanillin: dark blue. 
 
IR (film) 
~
V (cm-1):  3081 (w), 2956 (s), 2930 (s), 2894 (s), 2857 (s), 1742 (s), 1698 
(s), 1473(s), 1361.31 (m), 1303 (m), 1255 (s), 1117 (m), 1094 (vs), 992 (w), 836 (s), 
775 (s). 
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1H NMR (400 MHz, CDCl3): δ (ppm): 6.952 (s, 1H, H-21), 6.498 (s, 1H, H-19), 5.71-
5.75 (m, 2H, H 15, H-12), 5.41-5.49 (dt, 1H, 3J=15.0 Hz, 3J= 7.2 Hz, H-9), 5.30-5.35 
(dd, 1H, 3J = 9.1, 3J =2.0, H-8), 4.92-5.13 (m, 4H, H-13, H-14), 4.27-4.39(dd, 3J= 6.1, 
3J= 3.1, 1H, H-17), 4.112-4.124 ( q, 3J= 7.1,1H, H-7), 4.06-4.08 (t, 3J= 8.0, 1H, H-3), 
3.04-3.1 (m, 1H, H-6), 2.710 (s, 1H, H-23), 2.41-2.55 (m, 3H, H-2, H-16), 2.23-2.29 
(dd, 3J= 16.9, 3J= 6.2,1H, H-16), 1.79-2.09 (m, 7H, H-10, H-11, H-24), 1.25 (s, 3H, 
H-25), 1.04-107 (d, 2J= 6.38, H6-CH3) 0.96 (s, 3H, H-26), 0.88, 0.86 (s, 9H, SitBu), 
0.09, 0.03, 0.02, -0.08 (s, 3H, SiCH3) 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 214.3 (s, C-5), 169.75 (s, C-1), 163.5 (s, C-
20), 151.91 (s, C-18), 138.1 (d, C-16), 132.32 (d, C-8), 130.95 ( d, C-13), 130.18 (d, 
C-12), 125.87 (d, C-9), 117.88 (d, C-19), 115.82 ( d, C-17),  78.81  (d, C-15), 72.56 
(d, C-7), 64.8 (d, C-3), 52.54 (s, C-4), 47.60 (d, C-6), 42.13 (t, C-2), 36.1 (t, C-10), 
32.1 (t, C-11), 28.68 (t, C-14), 25.91 (q, SitBu), 24.94 (q, SitBu), 23.9 (q, C-21), 
19.05 (s, SiC(CH3)3), 18.24 (s, SiC(CH3)3, 17.1 (q, C-24), 17.0 (q, C-25), 16.1 (q, C-
22), 14.25 (q, C-23) -4.92, -4.9 (q, SiCH3), -3.66, -3.69 (q, SiCH3). 
 
MS (70 eV, EI): m/z (%): 717.2 (1<, M+), 580.2 (4) [TBSO+= C7-C22], 525.2 (4) 
[HO+=C1-C13], 469.1 (41) [HO+=C7-C22], 399 (100), 225.1 (80), 192.0 (100), 151 
(50). 
 
HRMS (EI): calcd C39H67NO5Si2S  for: 717.3 
                     Found:  717.4280 
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(3S,7R,9E,13E,16S)-4,8-bis(tert-butyldimethylsilyloxy)-5,5,7-trimethyl-16-((E)-1-(2-
methylthiazol-4-yl)prop-1-en-2-yl)oxacyclohexadeca-9,13-diene-2,6-dione. (97): 
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Grubbs catalyst first generation was added to a solution of diene 95 (74,4 mg, 0.11 
mmol) in CH2Cl2  (53 mL, 0.002 m), and the reaction mixture was stirred for 16 h at 
room temperature. The solvent was  removed  in  vacuo  and  the  crude  product  was  
purified  by  flash chromatography (pentane/Et2O 20:1) to give a mixture of                                                                                        
diastereomers 96 and 97  (Z/E  1:4,  50 mg,  68%, colorless viscous oil).  
 
Major isomer characteristic for trans-Olefin (97): 
 
General Data: C37H63NO5SSi2, MW: 690.14; DC: Rf = 0.37 (Pentene/Et2O 4:1), UV 
(+), vanillin: black. 
 
IR (film) 
~
V (cm-1): 2956 (s), 2930 (s), 2894 (s), 2857 (s), 1742 (s), 1698 (s), 1473(s), 
1348 (m), 1303 (m), 1255 (s), 1361 (m), 1255 (s), 1183 (m), 1097 (vs), 992 (w), 836 
(s). 
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1H NMR (400 MHz, CDCl3): δ (ppm): 6.916 (s, 1H, H-19), 6.526 (s, 1H, H-17), 5.48-
5.51 (m, 2H, H-8, H-9), 5.41-5.49, 5.24 (dd, 1H, 3J = 15.5, 3J = 7.9, H-12), 5.09-5.12 
(dd, 1H, 3J= 10, 3J= 2.8, H-13), 4.34-4.35 (dd, 3J= 6.9, 3J= 2.7, 1H, H-15), 4.11-4.32 
( t, 3J= 17.1,1H, H-7), 3.46-3.48 (t, 3J= 11.7, 1H, H-3), 2.93-2.97 (m, 1H, H-6), 2.69 
(s, 1H, H-21), 2.45-2.49 (dd, 3J= 16.9, 3J= 7.1,2H, H-2), 2.39-2.43 ( dt, 3J= 7.7, 3J= 
2.6 ,2H, H-14), 2.1 (s, 4H, H-10, H-11), 1.15-1-16 ( dd, 3J= 11, 3H, H-23), 1.13 (s, 
3H, H-23), 1.110 (s, 3H, H-25), 0.9, 0.8 (s, 2x 9H, SitBu), 0.17, 0.09, 0.029, -0.001 
(s, 2x3H, SiCH3). 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 214.13 (s, C-5), 171.20 (s, C-1), 164.7 (s, C-
22), 152.31 (s, C-20), 138.1 (s, C-18), 133.32 (d, C-15), 132.30 ( d, C-12), 131.35 (d, 
C-8), 120.90 (d, C-9), 117.82 ( d, C-21), 116.3 (d, C-19), 114.79 (t, C-13, C-14),  
78.61  (d, C-17), 74.06 (d, C-3, C-7), 53.08 (s, C-4), 48.99 ( d, C-6), 40.30 (t, C-2), 
37.5 (t, C-6), 33.1 (t, C-10), 31.1 (t, C-11), 26.68 (q, SitBu), 25.91 (q, SitBu), 22.9 (q, 
C-23), 19.85 (q, C-25),18.52 (s, SiC(CH3)3), 18.34 (s, SiC(CH3)3, 14.59 (q, C-24) -
4.93, -4.92 (q, SiCH3), -5.67, -5.89 (q, SiCH3). 
 
LC- MS: m/z (%): 691.4 (10) [M+H+], 558.2 (5), 560.2 (10), 286,2 (15), 287.0 (5). 
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(4S,7R,8S,9E,13E,16S)-4,8-dihydroxy-5,5,7-trimethyl-16-((E)-1-(2-methylthiazol-4-
yl)prop-1-en-2-yl)oxacyclohexadeca-9,13-diene-2,6-dione (98): 
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To a solution of 97 (20.9 mg, 0.0303 mmol) in CH3CN (3 mL) was added (HF)3.Et3N 
(1.2 ml, 7.36 mmol)  and Et3N (0.1 ml, 10% v/v) . The mixture was heated in a 45◦C 
oil bath for 20 hrs, after which it was cooled to room temperature and added to 
EtOAc (40 ml). The mixture was washed with 5% KH2PO4 (aq.) (2x30 ml) and the 
combined aqueous layers extracted with EtOAc (4x20 mL). The combined organic 
extracts were washed with brine (2X), dried over MgSO4 and concentrated. The 
residue was purified by flash chromatography (silica gel, Et2O) to afford 98 (7.1 mg, 
50%) as colorless solid. 
 
General Data: C25H35NO5S, MW: 461.61; DC: Rf = 0.37 (Et2O 4:1), UV (+), vanillin: 
black. 
 
IR (film) 
~
V (cm-1): 3440 (br m), 2930 (s), 2894 (s), 2857 (s), 1742 (s), 1698 (s), 
1473(s), 1348 (m), 1303 (m), 1260 (s), 1361 (m), 1255 (s), 1183 (m), 1097 (vs), 992 
(w), 836 (s). 
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1H NMR (400 MHz, CDCl3): δ (ppm): 6.916 (s, 1H, H-19), 6.526 (s, 1H, H-17), 5.6-
5.7 (m, 2H, H-9), 5.5-5.6, 5.24 (dd, 1H, 3J = 15.5 Hz, 3J = 7.4 Hz, H-8), 5.43-5.39 
(ddd, 1H, 3J= 17.1, 11.4, 6.3 Hz, H-12, H-13), 5.28 -5.32 (d, 3J= 20.1 Hz, 1H, H-15), 
5.1 (s, OH), 4.21-4.22 ( d, 3J= 4.1 Hz,1H, H-7), 3.10-3.14 (br s, OH), 2.8-2.93 (s, 1H,  
H-21), 2.55-2.71 (dt, 3J = 15.8, 7.0 Hz, 1H, H-6), 2.38 -2.47 (dd, 3J= 12.6, 6.4 Hz,2H, 
H-2), 2.10-2.23 ( dd, 3J= 12.6, 6.4 , 2H, H-14, H-10), 2.01-2.09 (s, 5H, H-14, H-10), 
1.69 ( s, 3H, H-23), 1.3 (s, 3H, H-25), 1.110 (s, 3H, H-23).  
 
 
13C-NMR (100 MHz, CDCl3): δ(ppm): 214.13 (s, C-5), 171.13 (s, C-1), 170.7 (s, C-
22), 152.31 (s, C-20), 138.1 (s, C-18), 133.32 (d, C-15), 132.80 ( d, C-12), 129.35 (d, 
C-8), 125.90 (d, C-9), 115.82 ( d, C-21), 116.3 (d, C-19), 113.79 (t, C-13, C-14),  
78.61  (d, C-17), 74.06 (d, C-3, C-7), 52.08 (s, C-4), 49.9 ( d, C-6), 40.30 (t, C-2), 
32.5 (t, C-6), 31.1 (t, C-10), 30.1 (t, C-11), 26.9 (q, C-23),21.85 (q, C-25), 14.59 (q, 
C-24)  
 
MS (70 eV, EI): m/z (%): 461.0 (1<, M+), 443 (4) [M+-H2O], 274 (34), 171 (38), 
168.0 (100), 151 (20). 
 
HRMS (EI): calcd C25H35NO5S for: 461.21 
                     Found:  461.22 
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